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ABSTRACT 
Infectious arthritis in growing pigs is considered the most common type of lameness 
encountered by veterinarians in the field. Efforts to mitigate, treat, and prevent infectious 
lameness by veterinarians have been problematic as the efficacy of antimicrobials for 
infectious arthritis is highly variable and diagnostic investigations often fail to yield 
actionable information about a field case.  The goals of this dissertation were to address 
specific questions within this broad problem from an applied clinical research perspective.   
The first research aim was to determine the most common primary diagnoses for 
lameness cases at a Midwest diagnostic laboratory and to collect descriptive data on 
infectious arthritis cases.  From the retrospective review of lameness cases involving joints 
and legs at the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL), it was 
reinforced that infectious arthritis was indeed a common diagnosis (about 40% of all 
lameness diagnostic lab cases) and highlighted that about 20% of lameness cases yielded 
inconclusive findings. These results directed the research towards the development of a 
refined joint fluid collection technique and a new diagnostic test to improve the diagnostic 
process for practitioners. Specifically, various injectable anesthetic protocols were compared 
in terms of utility for joint fluid collection and samples collected from that study were used to 
create reference intervals for fluid analysis and cytologic evaluation for swine joint fluid.  
These reference intervals serve as a core diagnostic tests for arthropathies in other species but 
did not exist publically previously for swine. Telazol, ketamine, and xylazine (TKX) were 
the most effective anesthetic combination for joint fluid sample collection and this study 
yielded sufficient number of high quality samples to create the reference intervals (37 tarsus 
and 46 carpus samples).  With these newly refined tools to diagnosis infectious arthritis, the 
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final component of the dissertation was to address treatment considerations and determine if 
a water soluble macrolide (tylvalosin [TVN]) distributes and maintains concentrations in the 
joint fluid of healthy pigs.  Tylvalosin was identified in joint fluid after oral gavage and 
during oral medication through ad libitum water access.  Substantial variation in water 
disappearance between individual pigs highlighted large dose ranges between pigs.  This was 
an unexpected finding and emphasized some of the challenges of treating groups of sick pigs 
with water soluble antimicrobials. Together, the studies in this dissertation contribute 
practical information for swine veterinarians related to the diagnosis and treatment of 
infectious arthritis in the field.  
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CHAPTER 1. INTRODUCTION AND LITERATURE REVIEW 
Introduction 
In recent years, due to the increased focus on animal welfare within the swine 
industry and the expansion of molecular diagnostic tools, lameness in growing pigs has 
become a key swine health topic for veterinarians and care takers. The most common 
types of lameness in growing pigs are arthropathies, a term which refers to abnormalities 
related to the joint(s). Within this umbrella term, infectious arthritis associated with 
bacterial pathogens garners the most focus from veterinarians as it is a common 
diagnostic finding and water-soluble macrolides are available for treatment.   
Despite the availability of diagnostic tests and antimicrobials, veterinarians report 
that infectious arthritis (IA) and joint-related lameness remain complex health challenges 
within their clinical practice. More specifically, lameness diagnostic investigations often 
fail to provide key information needed for clinical management decisions. Additionally, 
treatment in suspected or confirmed infectious arthritis cases is regularly reported to be 
unsuccessful.  Clearly there are knowledge gaps in our understanding of the diagnosis 
and treatment of infectious lameness in growing pigs. The body of literature on infectious 
lameness in swine is relatively small and the scope of the topic is extensive. 
The general approach of this dissertation to this broad problem is as follows: a) 
focus on applied research aims that can impact the clinical management of cases directly; 
b) review and understand the key etiologies of lameness broadly from diagnostic 
submissions to a Midwest veterinary diagnostic laboratory; c) develop and refine a new 
diagnostic assay applicable to common lameness etiologies to supplement and 
compliment current lameness diagnostic tools; d) review and, if needed, generate basic 
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pharmacokinetic data for water-soluble macrolide(s) to facilitate treatment decisions and 
provide more understanding of potential causes of treatment inefficacy in clinical cases.  
These objectives serve the long-term goal of this dissertation, which is to improve clinical 
management of infectious lameness cases in the field. 
Statement of specific research aims 
The specific research aims are: 1) perform a retrospective review of lameness 
cases associated with joints and legs from the Iowa State University (ISU) Veterinary 
Diagnostic laboratory (VDL); 2) develop and refine an injectable anesthetic protocol for 
the collection of antemortem joint fluid samples; 3) create reference intervals for fluid 
analysis and cytologic evaluation variables for swine joint fluid collected from healthy 
animals; and 4) determine synovial fluid concentrations of a water-soluble macrolide 
after gavage and ad libitum oral dosing.   
Organization of the dissertation 
This dissertation is in the journal print manuscript format.  The tables, figures, and 
references for each chapter are contained within that chapter. Each chapter is a 
manuscript formatted for a specific target journal. As per formatting guidelines from the 
ISU Graduate College, the stage of publication and author contributions are listed for 
each chapter as applicable.  
Literature review 
Arthritis refers to inflammation of the joint, including its associated synovial fluid 
and tissue. In IA cases in swine, the appendicular joints are prioritized for diagnostic 
sampling and as targets of antimicrobial treatment. The appendicular joints are key 
anatomical regions for IA and understanding their unique structure and physiology is 
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critical to the development and execution of the specific research aims listed above. This 
literature review will discuss joint structure and physiology as it is related to the 
pathogenesis of IA, the development of diagnostic tools for IA, and macrolide 
pharmacology. There are limited peer reviewed resources available on the swine joint and 
extrapolations from literature from humans and other species will be included and 
identified in this review, as applicable.  
Physiological structure of the joint 
The joint is considered a sequestered site within the body due to the tight 
regulation of compounds, potential pathogens and cells into and out of the joint space. 
There are two main structures that confer this unique characteristic of articular spaces. 
First is the synovium tissue lining the joint capsule that offers active and passive 
mechanisms to restrict entry of foreign molecules and pathogens into the joint.  Next is 
the joint fluid, composed of hyaluronic acid (HA), which is important for nourishment, 
regulation of inflammation and removal of foreign compounds within the joint. 
Synovium 
The fibrous joint capsule is lined by the synovium which is composed of 
synoviocytes cells, adipose, and fibrous cells.1,2 The synovium is highly vascularized and 
innervated.1 For molecules, cells, and bacteria to reach the synovial fluid they must pass 
through the synovium. This is a two-part process requiring movement out of the synovial 
capillaries and then diffusion through a dense network of extracellular matrix and 
synoviocytes.3 The synoviocytes form several layers between the capillaries and the joint 
space and are immersed in a dense collagen matrix.3,4 Within these layers, synoviocytes 
are divided generally into two types of cells. There are highly active phagocytic cells 
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with processes interdigitating between the cells (synovial type A cells) and there are 
paracrine cells which secrete hyaluronic acid (synovial type B cells).1,3,4 There is no 
basement membrane between synoviocytes and synovial capillaries and this allows small 
molecules (<10kda) to pass from the synovial capillaries through fenestrations and then 
diffuse through the synovium to reach the joint space.1 This is essentially an ultra-filtrate 
of the plasma. Larger molecules have reduced endothelial permeability and diffuse at a 
reduced rate through the synovium. 
Despite the limited movement of cells, molecules, and bacteria through this 
structure, Mycoplasma spp. and the infiltration of inflammatory cells have been identified 
using histology and immunofluorescence in synovium membranes in experimentally 
infected pigs.5  The exact mechanism for transport into the synovium and into the 
synovial fluid is unclear for Mycoplasma spp. but may be related to expression of 
endothelial cell ligand receptors or inflammation-associated fenestrations in the capillary 
synovium complex allowing migration of Mycoplasma spp. out of the capillary.6,7  The 
entry of bacterial pathogens into the joint from the blood stream requires movement 
through the synovium, thus it is an important physical and immunologically active barrier 
to joint infections.  
Role of Synovium in Inflammation 
When infectious arthritis is diagnosed in a joint, gross and histologic indications 
of inflammation are commonly detected.  The synovium, when inflamed, may appear 
edematous, hyperemic, and/or proliferative. A fibrinous membrane and yellow, red or 
brown discoloration may also be noted visually when assessing inflamed synovium.8  
Increased capillary permeability, translocation of leukocytes into the synovium, and 
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increased activity of synoviocytes are all documented changes associated with 
inflammation of the joint.6,7 Histologically, the tissue changes with synovitis are 
generally non-specific and are dynamic during the progression from acute infection to 
resolution or chronicity. Initially, edema and infiltration of various inflammatory cell 
types, typically lymphoplasmacytic or mixed cell infiltration, are observed 
microscopically. Synovial cell hyperplasia, lymph and capillary dilation, and 
hypertrophied synovial villi may also be noted.  In more chronic cases of synovitis, 
fibrosis, synovial villi hypertrophy, and mild lymphocyte infiltrates are noted.7,8 
Histological and gross changes to the synovium have been characterized for various 
arthropathies in animals and humans for osteoarthritis,9-11 ostechondrosis,12 and 
Mycoplasma spp. associated arthritis.8,13-16 
Much of the inflammatory changes noted in infectious arthritis cases are mediated 
by the type A synovial cells which are key phagocytic cells within the region.3 Synovitis 
results in the release of inflammatory mediators and catabolic enzymes into the synovial 
fluid which negatively affects the synthesis of articular cartilage matrix components.1,17  
The synovium also contains mechanoreceptors, nociceptors, toll-like receptors, and 
receptors for interleukins, growth factors, and chemokines.9 The complex 
microenvironment of the synovium is critical for host defense and initiation or 
suppression of the immune response within the joint.  
There are no pathognomonic synovial lesions associated with IA in pigs but 
synovial histology is a useful tool to provide context to synovial fluid clinical pathology, 
polymerase chain reaction (PCR), and culture results. Thus, gross and histological 
evaluation of the synovium will be a key assessment tool for IA in the retrospective 
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diagnostic lab case review (specific research aim 1, Chapter 2) and in the creation of 
reference intervals for clinical pathology variables for healthy swine joint fluid (specific 
research aim 3, Chapter 4).  
Synovial Fluid 
Synovial fluid is composed of hyaluronic acid secreted by type B synoviocytes.  
The fluid serves multiple functions in the joint including lubrication, delivery of nutrition 
to cartilage, removal of waste products, nociception, and regulation of inflammation.1,2   
The fluid is fairly permeable to small molecules such as amino acids and glucose but it is 
anionic and traps large molecules (>67 kDa) and cells, including leukocytes.6 The 
trapping of leukocytes and regulation of inflammatory cascades is crucial to joint health 
as inflammatory mediators including cytokines, complement, antibodies and digestive 
enzymes,  damage the cartilage and synovium.  If cells, pathogens and foreign molecules 
do reach the synovial fluid, they can be promptly removed from the joint space by several 
mechanisms. Molecules are drained out of the joint space by venules and lymphatics 
thereby making it difficult to achieve and sustain concentrations of exogenous 
compounds, such as antimicrobials, in the joint.6 
Synovial fluid is also critical to the pain signaling pathway. The elastoviscostic 
properties of hyaluronic acid in normal joint fluid adequately transfer force associated 
with weight bearing and movement to joint tissues without causing physical or 
mechanical stress to the joint. In joints affected by inflammation, joint fluid viscosity is 
reduced and HA is degraded from its linear polymer form by catabolic enzymes produced 
from inflammatory cascades in the synovium.2,6,7,18 As the synovium capillaries become 
expanded and leaky due to inflammation, additional macromolecules and cells enter the 
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synovial fluid changing its pH and volume and, ultimately, the protective biochemical 
properties of the synovial fluid.2,6,7 As a result, there is more transfer of force to the joint 
tissue. Increased load bearing and fluid volume within the joint sensitize and trigger 
nociceptive and mechanoreceptors resulting in pain. As well, cartilage integrity suffers 
with reduced nutrition from the synovial fluid and direct interaction with degradation 
enzymes associated with inflammation.19 HA polymer fragments themselves can directly 
trigger pro inflammatory cascades and sensitize nociceptors in nerve end terminals in the 
joint.19  
Synovial fluid has also been described as a critical biomarker for joint disease in 
other species such as cats, dogs, and horses because it is so responsive to changes in joint 
homestasis.20-27 In horses, fluid analysis and cytologic evaluation of synovial fluid is 
described as the most important diagnostic tool for diagnosis of infectious arthritis.27  
Based on its use as a diagnostic tool in other species, it appears there are opportunities to 
improve and expand diagnostic tools for swine arthritis using joint fluid and clinical 
pathology. Unlike horses and humans, ante mortem joint fluid collection is not a 
routine swine clinical technique and reference intervals for clinical pathology variables 
for joint fluid are not available for swine. Thus Chapter 3 (specific research aim 2) 
describes the refinement of anesthetic protocols for the collection of ante mortem joint 
fluid samples. Additionally, Chapter 4 (specific research aim 3) details the creation of 
reference intervals for fluid analysis and cytologic evaluation for joint fluid samples 
collected from healthy swine.  
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Treatment of Arthritis: Considerations for Antimicrobial Pharmacology 
General Properties of Macrolides 
Macrolides are commonly used to treat infectious arthritis in swine due to their 
pharmacologic properties and practical considerations related to the availability of 
Federal Drug Administration (FDA) approved formulations for swine. This drug class is 
composed of weak bases and is considered bacteriostatic due to their ability to inhibit 
protein synthesis by interfering the 50s ribosome. They have little to no efficacy for 
anaerobic or aerobic gram-negative bacteria but are useful for gram-positive, 
Mycoplasma spp., Erysipelaothrix spp., and Bordatella spp. infections. Macrolides 
generally have a large volume of distribution (Vd) resulting in high levels of tissue 
concentrations, particularly in the lungs. Despite the high volume of distribution, there is 
not a macrolide-specific transport receptor into the joint space through the synovium. 
Macrolides must use passive diffusion to leave the capillaries and enter the synovial 
tissue.6 This drug class is also susceptible to ion trapping as they are weak bases and 
become trapped in cells that are more acidic than plasma. This characteristic is 
pronounced in the lysosome and phagolysomes of neutrophils and macrophages. As these 
cells which contain “trapped” macrolides are inflammatory cells and the organelles are 
used for digesting phagocytosed pathogens, this intracellular trapping phenomenon could 
be a critical component to treatment success in inflamed tissues.6,28   
Conversely, inflammation reduces pH within the joint space, decreases synovial 
fluid viscosity and increases blood flow to and from the inflamed area. These factors can 
reduce macrolide activity and expedite the passive removal of the macrolide (and 
inflammatory cells) from the joint space via lymphatics and small venules.6,28 Thus 
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macrolides possess some characteristics that may be both detrimental and beneficial to 
their efficacy in inflammatory environments, such as an arthritic joint.  
Oral bioavailability of macrolides is generally low depending on the formulation 
and elimination is largely through hepatic metabolism.28 Spectrum of activity, half-life, 
and volume of distribution do vary between specific macrolides and the selection of a 
specific macrolide over another for use in a clinical case may be critical for success. For 
example, tilmicosin and tulathromycin have much larger Vd and longer half-lives than 
tylosin and tylvalosin, but have been reported to have a reduced spectrum against 
Mycoplasma spp. compared to tylosin.28 
Specific Macrolides for the Treatment of Infectious Arthritis 
Amongst available macrolides licensed by the FDA for swine, tylosin and 
lincomycin (a lincosamide, but behaves similarly to macrolides) are commonly used to 
treat IA and are available in water-soluble, injectable, and feed formulations. There are 
several other macrolides available for swine but only lincomycin and tylosin in injectable 
formulations have indications related to IA. Tilmicosin and tulathromycin are available in 
injectable form but are not labeled for the treatment of arthritis or lameness.  There are no 
feed grade macrolides with label indications for lameness or arthritis and extra label use 
of feed medication is illegal in the United States (US). In 2012, tylvalosin entered the US 
market as a water-soluble macrolide with zero day withdrawal indicated for proliferative 
enteropathy associated with Lawsonia intracellularis.29  Due to the practical advantages 
of water-soluble products and tylvalosin’s pharmacological attributes as macrolide, it has 
been used in the field by practitioners for the treatment of arthritis, particularly for cases 
associated with Mycoplasma spp.  
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Regardless of the antimicrobial selected for treatment, there is limited 
pharmacokinetic or clinical trial data on the treatment of IA available on Google Scholar, 
PubMed, and the American Association of Swine Veterinarians (AASV) Swine 
Information Library. There is one conference proceeding detailing the levels of 
lincomycin detected in the joint after administration in the feed.30 Concentrations of 
lincomycin in the carpal joint fluid (0.10 µg/mL) were the same for two doses of 
lincomycin administered in the feed (110 mg/kg and 220 mg/kg).30 Beyond this 
proceeding, there are no other publicly available sources of swine joint pharmacological 
data for macrolides. This knowledge gap is to the detriment of veterinarians seeking to 
apply evidence based medicine to their management of IA. Clinical trials and field trials 
assessing efficacy of specific macrolide products for specific clinical syndromes would 
be ideal.  In the absence of that data, basic pharmacokinetic data such as half-life, volume 
of distribution, and concentration attained in target tissues for selected pathogens could 
help inform treatment decisions.  
Due to recent practitioner interest in tylvalosin for treatment for arthritis and the 
relative lack of pharmacologic data on all swine macrolides, a core aim of this 
dissertation is to determine if tylvalosin distributes to the joint and if so, to further 
characterize concentrations attained in the joint over the course of administration through 
the water.  Chapters 5 and 6 (specific research aim 4) focus on generating much needed 
pharmacologic information on a tylvalosin, a macrolide used currently in the field for 
the treatment of infectious arthritis.   
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Summary 
Objectives  
 The objective of this review was to categorize and quantify the most common 
causes of joint- or leg- associated lameness by summarizing available information from 
cases presented to the Iowa State University (ISU) Veterinary Diagnostic Laboratory 
(VDL) between 2010 and 2015.  
Materials and Methods  
 All cases of lameness or locomotor dysfunction in pigs between 7- and 40- 
weeks-of-age submitted to the ISU VDL between May 1st 2010 and April 30th 2015 were 
retrieved. After reviewing the cases to meet inclusion criteria such as field cases 
involving joints and legs, inclusion of tissue samples for histology and age and/or weight 
criteria, the cases were individually reviewed and assigned a primary and secondary 
diagnosis. The criteria for the diagnostic categories assigned to the cases are reported in 
the paper.  
Results 
 There were 464 of 1847 cases retrieve that met the inclusion criteria. The most 
common primary diagnosis was represented almost equally across four diagnosis 
categories, each accounting for about 20% of the cases.  These four primary diagnoses 
are MHS, metabolic bone disease, infectious arthritis due to bacterial infection, and 
lameness with inconclusive findings.  There were 23% (108/464) of the cases that had a 
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secondary diagnosis with metabolic bone disease (29%; 31/108) identified as the most 
common.  
Implications 
 Accurate diagnosis is key for selection of effective interventions and setting 
expectations for likelihood of treatment success. This study reinforces the importance of 
careful clinical examination, proper sampling, and confirming cause(s) with appropriate 
diagnostic testing for accurate diagnosis of lameness.   
Introduction 
 Joint- and leg-associated lameness in growing pigs is a common diagnostic and 
therapeutic challenge for swine veterinarians. A diagnostic investigation usually starts 
when the caretaker identifies lameness in a group of pigs and notifies a veterinarian for 
an assessment which may involve submission of samples to a veterinary diagnostic 
laboratory (VDL). In recent years, there has also been a great interest in Mycoplasma 
hyosynoviae (MHS) which is considered one of the major primary causes of joint-
associated arthritis, but the organism may only be present transiently within the joint 
making diagnosis challenging.1 Inconclusive diagnostic testing increases uncertainty of 
diagnosis and decreases confidence in specific recommendations for therapy. Lameness 
submissions that do not generate actionable information or support a specific etiology for 
the lameness are reported by practitioners, but the frequency of these cases from 
veterinary diagnostic laboratory submission databases has not been quantified and 
reported in the peer reviewed literature.  
 Prudent use with increasing regulation and oversight of antimicrobials in swine 
herds reinforces the value of an accurate diagnosis to support treatment decisions and to 
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investigate non-response to treatment.  Diagnostic laboratory data is not equivalent to 
field prevalence; however, it is helpful for swine practitioners to be aware of the 
spectrum and relative frequency of lameness causes reported by a Midwest US VDL. 
Insight into capabilities and expectations of laboratory testing can assist veterinarians in 
proper sampling, test selection, interpretation of results as well as provide insights into 
the relative importance of specific lameness etiologies for future research priorities. 
Specifically, insights from a review of submission trends and diagnostic approaches for 
cases of acute MHS synovitis may inform improvements in sampling and testing for this 
common etiology of growing pig lameness. Beyond general recommendations in swine 
texts there is limited published information on submission practices for joint-associated 
lameness cases.2 
 The objective of this review was to categorize and quantify the most common 
causes of joint- or leg- associated lameness by summarizing available information from 
cases presented to the Iowa State University (ISU) VDL between 2010 and 2015. The 
second objective of this study was to summarize submission trends and features of those 
cases with a diagnosis of MHS.   
Methods 
 All cases of lameness or locomotor dysfunction in pigs between 7- and 40- 
weeks-of-age submitted to the ISU VDL between May 1st 2010 and April 30th 2015 were 
retrieved for review using the ISU VDL laboratory information management system 
(LIMS). Each individual laboratory accession was considered a single case irrespective of 
number of samples submitted. The three specific search criteria, selected with aid of VDL 
diagnosticians and information technology specialists, were: porcine cases, samples 
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included tissues examined by histopathology and at least one diagnostic code was 
assigned by a diagnostic pathologist; the 23 diagnostic codes available for lameness 
include those specific for MHS and Mycoplasma hyorhinis (MHR) PCR and/or a 
Mycoplasma spp. culture.  
 For each qualifying accession (case), the submission form and laboratory report 
were reviewed and relevant information extracted into a spreadsheet.  The information 
extracted from the LIMS included accession number, date, age, age unit, diagnostic code, 
diagnostician, histopathology observations and all tests performed with results. The clinic 
and bill party information was used to remove those cases that were not diagnostic 
investigations of field cases, such as research and teaching accounts. Client name, 
submitting veterinarian, premise ID were not extracted from the database to maintain 
confidentiality and anonymity. Permission was granted from the ISU VDL for this study.  
 All cases were individually reviewed to ensure each met the inclusion criteria of 
age/weight (7 to 40 weeks or >16 kg), histopathology performed, and case type (must be 
a field case – research cases excluded).  If the age or weight was not present in the data 
output from LIMS, the case remained in the database and the original submission sheet 
was cross referenced for any submitting information that referenced age or weight. If this 
age/weight data was not included on the submission sheet, the case was removed.  Cases 
must have included joint tissue for histology to be included in this database; cases. Cases 
only involving serum, oral fluids and/or swabs were excluded.  
 To confirm that all qualifying cases did involve lameness and locomotion 
dysfunction, additional information from the submission sheet and final report was 
entered into the spreadsheet. Specifically, the history, submission notes on the submission 
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sheet, and the final diagnosis and comments from the diagnostician on the final report 
were entered and evaluated. Specifically, the case had to include terms involving 
lameness and/or locomotion in the history and that the diagnostic testing completed had 
to be relevant to locomotion dysfunction, lameness or joint disease. For example, a case 
may have M. hyorhinis septicemia as a diagnostic code but if the history did not report 
any information related to lameness and legs or joints were not submitted with the case, 
then the case was excluded.   
After confirming that all cases remaining in the database involved locomotion 
dysfunction and meet the other inclusion criteria mentioned above, the cases were 
individually reviewed and assigned a primary and secondary diagnosis. Specific criteria 
for each diagnosis was created and applied uniformly to the cases (Table 1). Unless 
specified on Table 1 as “if available,” all criteria listed for a given category must have 
been satisfied for a given diagnosis to be assigned to a case.  Criteria for each diagnosis 
were determined by peer reviewed literature and with consultation with a diagnostician at 
the VDL. Secondary diagnosis refers to a diagnostic category that was relevant to the 
case but was not the main or most acute cause of lameness.  This determination was made 
from comments in the final report by the diagnostician, severity and prevalence of the 
abnormalities and understanding of the pathophysiology of the given diagnostic category 
in question. 
 For the assignment of primary and secondary diagnostic category, the unit of 
assessment was the entire submission, not each individual pig within a case. 
  
21 
 
 
 Submitter trend analysis for Mycoplasma hyosynoviae cases 
 Cases that were assigned MHS as the primary diagnosis were then reviewed 
further to summarize case attributes related to submission habits. Specifically, the 
following data points were collected and summarized: year, inclusion of a history on 
submission sheet (Yes/No), inclusion of differential diagnosis in history (Yes/No), 
number of differential diagnosis included in history, type and number of specimens 
submitted, number of MHS PCRs performed per case, number of animals from which the 
submitted specimens were procured, number of diagnostic tests requested, types of 
diagnostic test requested, results from non-MHS related tests performed, and secondary 
diagnosis.  
Results 
Primary and secondary diagnosis for all lameness cases 
 The results of each step of the case database creation process are presented in 
Figure 1. In Table 2, the primary and secondary diagnosis associated with each of the 464 
lameness cases is summarized. There were 93 (20%) cases assigned MHS as the primary 
diagnosis as per the case definition criteria in Table 1. The most common primary 
diagnosis was represented almost equally across four diagnosis categories, each 
accounting for about 20% of the cases.  These four primary diagnoses are MHS, 
metabolic bone disease, infectious arthritis due to bacterial infection, and lameness with 
inconclusive findings.  There were 23% (108/464) of the cases that had a secondary 
diagnosis with metabolic bone disease (29%; 31/108) identified as the most common.  
Trend analysis for Mycoplasma hyosynoviae cases 
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 The number of MHS cases per full calendar year fluctuated between 7 (2011) and 
34 (2013). A review of MHS case characteristics determined that the mean age of pigs 
diagnosed with MHS was 18.3 weeks (range 10 to 32 weeks). On average, MHS cases 
conducted 2.4 MHS PCRs per case (range 1 to 16). The cycle threshold values for MHS 
PCR were generally between 30 to 35 (range 20.3 – 42.9) and for cases requesting three 
or more MHS PCR tests, on average, 50% of the MHS PCRs performed on a case were 
positive.  
 An analysis of submission trends revealed that 99% (92/93) of cases included at 
least one word in the history on the submission form. Seventy-one percent (66/93) of 
cases listed differential diagnoses with their submission form and of these cases, 80% 
(53/66) listed multiple possible differential diagnosis.  Nine cases (10%) listed MHS as 
the sole differential. For cases that listed more than one differential, the most common 
differentials were MHS (62%; 38/53), MHR (42%; 22/53), Haemophilus parasuis (42%; 
22/53), Streptococcus suis (40%; 21/53), and Erysipelothrix spp. (36%; 19/53). 
Nutritional/metabolic, OCD, and trauma were listed 19 (36%; 19/53) times cumulatively.   
 The majority of submitting veterinarians selected diagnostic testing to be at the 
discretion of the VDL diagnostician (69%; 64/93) while 15% (14/93) left the test 
selection portion of the diagnostic form completely blank.  Another 15% (15/93) of 
submitting veterinarians selected at least four unique diagnostic tests for their case.  
 Sample types submitted included 43% (40/93) of cases with at least one whole 
leg, 27% (25/93) at least one whole pig, and 25% (23/93) at least one joint swab or fluid.  
On average 3.7 (range 1 to 14) legs were submitted per case where 90% (36/40) 
submitted at least two and 45% (18/40) submitted 3 to 8 legs.  On average, 4.4 (range: 1 – 
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25) whole pigs were submitted where 36% (9/25) submitted two whole pigs, 28% (7/25) 
submitted 3 to 5 pigs, and 24% (7/25) submitted six or more pigs. Considering all sample 
types, submissions contained samples from 2.9 animals (range 1 to 25).  
 There were 30/93 (32%) cases in which there were multiple diagnosis, with OCD 
(27%; 8/30) and non-mycoplasma bacterial (27%; 8/30) being the most common 
secondary diagnosis.  
 The most commonly requested test for pathogens other than Mycoplasma spp. 
was aerobic culture and on average each case involved 2.4 cultures (range 1 to 37), of 
which 78% (171/220 total cultures) returned no significant growth. This does not include 
Erysipelothrix specific cultures.  Erysipelas was commonly listed as a differential (36% 
of cases; 19/53) but none of the cases listed skin lesions as part of the history or gross 
lesion findings. Almost half of the MHS cases (45/93) cases performed at least one 
Erysipelothrix culture or PCR with each case averaging 2.5 Erysipelothrix assays. Of all 
these cases, however, only one (2%) returned a positive result.  
Discussion 
 This review summarizes the most frequently observed lameness diagnostic 
categories for case submissions involving joints and legs at the ISU VDL between 2010 
and 2015.  A similar study reported the frequency of diagnosis of arthritis, specifically 
MHS and MHR cases between 2003 and 2010 at the ISU VDL.5  There were 431 clinical 
cases with infectious arthritis during that time period and MHS represented 17% of the 
arthritis cases. 5   There were more MHR cases identified in that study than reported here, 
but that study included pigs <7 weeks of age. Findings from the current study are also 
consistent with another summary of arthritis cases from 2003 to 2014 at the ISU VDL.6 
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This review found that 25% of the cases were idiopathic, 20% were MHS, 24% bacterial 
and 12% were MHR based on the diagnostician code alone.6  These results reinforce that 
many diagnostic investigations do not reveal a clear etiology of the lameness as a 
consequence of diagnostic testing alone.  
 Studies aiming to summarize lameness etiologies have been performed in the 
context of field cases.  One Danish study looked at the microbiological causes of 
lameness in pigs at slaughter in Denmark. Erysipelothrix rhusiopathiae and MHS 
composed about 10% of the cases each, while 70% joints were sterile. Gross changes to 
the joints were observed with E. rhusiopathiae and MHS associated arthritis but gross 
pathological changes in the sterile joints were non specific.7 In another Danish slaughter 
pig study, MHS was isolated from 60% of the pigs with arthritis in three of the five herds. 
Claw lesions (22%) and severe OCD (10%) made up the second and third most common 
diagnosis across all herds.8  
 From the results of this analysis and previous studies, it appears that MHS is an 
important contributor to arthritis, but there are several other important known and 
unknown etiologies associated with the lameness.  In this study, the four diagnostic 
categories (idiopathic, MHS, metabolic bone disease, and bacterial) composed about 80% 
of the cases and about a quarter of the cases had at least one other lameness-associated 
abnormality.  This reinforces that lameness is often multifactorial, and that many swine 
lameness processes may be cumulative creating difficulty in assigning single etiology 
causation. Additionally, the high rate of idiopathic and non-infectious lameness cases 
should prompt practitioners to perform complete diagnostic investigations before 
implementing expensive interventions or antibiotic treatment in the field.  
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 Lameness with inconclusive findings was the most commonly assigned (22% of 
cases) diagnostic option for this case review. It is possible that submitter bias, behaviors 
or inattention to details such as animal selection, sample selection, sample handling, and 
test selection could artificially increase this number.  For example, in cases where 
practitioners submitted one intact joint, it could be possible that with additional 
specimens, that case could have received a diagnosis.   
 Conclusions obtained by retrospective analysis of data from a VDL should not be 
over interpreted and any extrapolation of the findings should be approached carefully.  
The data from this review is not field prevalence data. For each case, there were multiple 
sources of bias that make standardization and objective analysis of VDL data very 
difficult.  First, information is limited to the submission sheet, submitted specimens, and 
tests requested or VDL diagnostician’s decision on testing.  Each case did not test for all 
possible causes of lameness and the case search criterion focused on arthropathies.  Since 
the completion of this analysis, multiple case reports have highlighted neurological and 
vesicular viral pathogens as important lameness etiologies, which were beyond the scope 
of this retrospective review at the time.9-13  Furthermore, the analysis was focused on 
infectious arthritis, specifically MHS, and the MHS case definition was targeting acute 
cases. This review also did not include sows, boars, gilts, suckling, or nursery pigs; all of 
which contend with diverse lameness challenges.  
 Additionally, the retrospective case review process involves subjective steps 
completed by the veterinarian, laboratory technician, diagnostician and case reviewer. 
For example, a diagnostician may interpret histopathologic findings differently depending 
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upon their experience, current/popular health priorities within the industry, areas of 
expertise, and information provided about the case by the submitting veterinarian.  
Implications 
In this study, the four diagnostic categories of idiopathic, MHS, metabolic bone 
disease, and bacterial composed about 80% of the cases.  These four diagnoses have quite 
different etiologies and pathogenesis and require different intervention strategies. 
Accurate diagnosis is key for selection of effective interventions and setting expectations 
for likelihood of treatment success. This study reinforces the importance of careful 
clinical examination, proper sampling, and confirming cause(s) with appropriate 
diagnostic testing for accurate diagnosis of lameness.   
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Table 1. Diagnostic criteria for each diagnostic category applied to cases associated with 
joint/leg lameness 
Diagnostic 
Category 
Criteria for inclusion into each diagnostic category 
Lameness: 
abnormal 
diagnostic 
testing results 
with 
inconclusive 
findings 
(Lameness with 
inconclusive 
findings) 
• lameness reported by practitioner and/or diagnostician  
• histology of joint revealed mild non-specific changes to the 
synovial tissue  
• additional testing not performed or results of additional testing 
were inconclusive or not significant 
• description of inconclusive or nonspecific joint changes included 
in final report by pathologist [if available]* 
Mycoplasma 
hyosynoviae 
(MHS) 
• specimens submitted from animals with clinical lameness and/or 
joint swelling  
• at least one positive MHS polymerase chain reaction (PCR) result 
on joint fluid or joint tissue  
• histology lesions consistent with MHS as per diagnostician 
comments in histology report and/or published histology findings 
associated with experimental and field MHS cases1,3,4  
Metabolic bone 
disease 
• abnormal results on any calcium, phosphorus, vitamin D assay 
and/or bone ash/density tests. Cases did not have to run all of 
these assays to be included in the metabolic bone disease category 
• diagnostician comments that abnormality is contributing to 
locomotion issues  
Infectious 
(bacterial, non-
mycoplasma 
species) 
• histology on synovium indicative of infectious (non-mycoplasma) 
process  
• significant findings on culture†  
• gross description of fluid indicative of infection, ie. purulent, 
serosanguinous [if available] 
• positive PCR results on molecular testing for Erysipelothrix spp. 
or Haemophilus parasuis from joint specimens [if available] 
Lameness: no 
abnormal 
findings 
• Lameness reported by practitioner and/or diagnostician 
• Culture with no significant findings  
• MHS PCR negative  
• Histology of joint revealed no changes to synovial tissue  
Osteochondrosis 
(OCD) 
• Gross or histologically observed cartilage defects in articular 
cartilage  
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Table 1. Diagnostic criteria for each diagnostic category applied to cases associated with 
joint/leg lameness (continued) 
Diagnostic 
Category 
Criteria for inclusion into each diagnostic category 
Mycoplasma 
hyorhinis 
• MHR PCR positive or MHR culture positive on joint fluid or joint 
tissue  
• Histological changes to the synovium consistent with MHR  
• Systemic gross and histological lesions from other tissues 
submitted indicative of systemic MHR cases [if available] 
• Serosanguinous synovial fluid or fibrin in synovial fluid [if 
available] 
Trauma • Fractures unrelated to abnormal bone histology indicative of 
metabolic bone disease [if available] 
[OR] 
• Bursitis related to physical contact with slats, as associated in 
diagnostician comments  
Osteomyelitis • Bacterial infection of the bone as per gross and/or histological 
assessment of the bone  
• Significant findings on culture [if available] 
*[if available] indicates that for some of the cases this information or specimen may not be 
available, and that relevant tests to this diagnostic category may or may not have been performed. 
†Significant findings refer to growth of a bacterial species associated with arthritis as per the 
bacteriologist or published literature.   
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Table 2. Primary and secondary diagnosis for 464 lameness cases in growing pigs from 
a retrospective case survey at the Iowa State University Veterinary Diagnostic 
Laboratory between May 2010 and April 2015.  
Diagnosis Primary 
Diagnosis 
Secondary 
Diagnosis 
Lameness with inconclusive findings 101 22% 27 25% 
Mycoplasma hyosynoviae 93 20% 1 1% 
Metabolic bone disease 86 19% 31 29% 
Infectious (bacterial) 81 18% 18 17% 
Lameness: no abnormal findings 43 9% 0 0% 
Osteochondrosis (OCD) 29 6% 18 17% 
Mycoplasma hyorhinis 19 4% 4 4% 
Trauma 10 2% 8 7% 
Osteomyelitis 2 0.4% 1 1% 
Total  464 100% 108 100% 
 
 
 
 
Number of cases returned from database from initial 
search
1847
Number of cases meeting inclusion criteria related to age/
weight of pigs, date, case type and relevant diagnostic 
tests performed
1019
Number of cases involving locomotion dysfunction in 
growing pigs
464
Number of cases with Mycoplasma hyosynoviae as the 
main diagnosis
93
Figure 1.  Summary of case selection process from a retrospective survey of lameness 
cases from the Iowa State University Veterinary Diagnostic Laboratory between May 
2010 and April 2015. 
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Summary 
Objective 
This study compared the suitability of four anesthetic protocols for percutaneous 
aspiration of synovial fluid from healthy swine in field conditions. A supplemental 
objective was to assess the iatrogenic impact of antemortem joint sampling by monitoring 
lameness, joint swelling and synovial histology for seven days after procedure.   
Materials and methods 
Twenty-four 80-90 kg finisher pigs were randomly allocated into one of four 
treatment groups. Each group was given one of four anesthetic combinations 
intramuscularly: telazol-ketamine-xylazine (TKX), telazol-ketamine-acepromazine 
(TKA), ketamine-acepromazine with a lidocaine epidural (KAL), or telazol-
acepromazine with a lidocaine epidural (TAL). Once anesthetized, synovial fluid was 
collected aseptically from one carpus and tarsus joint per pig. The anesthetic protocols 
were evaluated in terms of successful achievement of general anesthesia, time to sternal 
and time to standing recovery.  Joint swelling and lameness assessments were completed 
on days two, four, and seven post-sampling. On day seven, pigs were euthanized and 
synovium was collected from each sampled joint for histologic evaluation.  
Results 
TKX and TAL were the only anesthetic combinations that provided an adequate 
depth of anesthesia for fluid collection to occur. Mean (standard deviation) time to sternal 
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for TKX was 125 (26) minutes and for TAL was 198 (28) minutes. There was no 
evidence of infection post-aspiration in any of the sampled joints.  
Implications 
TKX was the most effective anesthetic protocol for antemortem joint fluid 
collection. Antemortem joint fluid collection was not associated with significant joint 
tissue damage and can be a useful diagnostic tool for infectious arthritis.  
Keywords 
swine, joint fluid, telazol, ketamine, xylazine 
Introduction 
Infectious arthritis in swine is an important cause of lameness in growing pigs.1  
Diagnosis of infectious lameness in pigs can be difficult due to the transient nature of 
joint pathogens.  Diagnostic investigations generally involve post-mortem samples 
substantially limiting the number of available specimens to submit for testing. An 
antemortem joint fluid collection technique would offer practitioners additional flexibility 
to collect diagnostic samples without having to sacrifice animals. A challenge of this 
technique is achieving sufficient plane of anesthesia for the procedure in the field. 
Although there are published recommendations for injectable anesthesia for pigs, these 
references typically do not state the effectiveness of the protocols for specific procedures, 
such as percutaneous joint fluid aspiration.2-5  Additionally, there are no reports on the 
impact of antemortem joint fluid collection on lameness and synovial damage post-
procedure.   
The primary objective of this study was to compare the utility of four anesthetic 
protocols for antemortem joint fluid collection. The protocols were evaluated in terms of 
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successful achievement of anesthesia, time to recovery, and cost of the protocol.  The 
secondary objective was to assess the iatrogenic impact of percutaneous joint fluid 
collection by monitoring lameness and joint swelling for seven days post sample 
collection and assessing histology at day seven.   
Materials and methods 
Animals, housing, feed, and water  
The trial was approved through the Iowa State University Institutional Animal 
Care and Use Committee.  Prior to the initiation of the trial, pigs were housed in 
partially slatted pens in groups of 15 to 20 in a feeder to finisher barn with a total group 
size of approximately 200. At selection for the trial, 80-90 kg pigs were moved from 
the group housing to individual pens for the procedures described below. Pigs were first 
assessed while standing and observed while walking to ensure they did not display 
lameness or swollen joints. Pigs were also given a physical exam by a veterinarian, 
which included joint palpation, and pigs had to be free of clinical signs to be included 
in the trial. Once pigs were fully recovered from anesthesia, the pigs were returned to 
their original group pens.   
All pigs were fed ad libitum commercial finisher feed without antibiotics for the 
duration of the trial and had free access to water ad libitum. The diets met the National 
Research Council requirements for swine.6  Neither feed nor water were not withheld 
from pigs prior to anesthesia.  
Treatment allocation 
There were 24 pigs in the trial and the group was a mix of barrows and gilts. 
After selection, pigs were weighed, ear tagged, and randomly allocated using a random 
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number table to one of four anesthetic protocols. Generally, for each protocol, an initial 
minimum dose was given and then additional step dosing was done until anesthesia was 
sufficient for the procedure or until a priori maximum dose was achieved within 1.5 
hours of the initial dose. If the maximum dose was achieved and an insufficient plane 
of anesthesia was attained for joint fluid collection, the pig was not given any more 
anesthetic agents and was monitored until recovery.  
Group TKX received an initial intramuscular (IM) injection of 4.4 mg/kg telazol 
(tiletamine HCl and zolazepam HCl injection, Zoetis, Kalamazoo, MI), 2.2 mg/kg 
ketamine (Zoetis, Kalamazoo, MI), and 4.4 mg/kg xylazine (VetOne/Akorn, Inc. Lake 
Forest, IL) combined in the same syringe3,5 with a maximum cumulative dose of 4.4 
mg/kg of ketamine and 8.8 mg/kg each of xylazine and telazol.  
The TKA group received an initial IM injection of 0.03 mg/kg acepromazine 
(VetOne/Akorn, Inc. Lake Forest, IL), 2.2 mg/kg of ketamine, and 4.4 mg/kg telazol 
combined in the same syringe3 with a maximum cumulative dose of 10 mg/kg telazol, 
0.07 mg/kg acepromazine, and 5 mg/kg of ketamine. 
Group TAL received an initial IM injection of 0.3 mg/kg acepromazine and 4.4 
mg/kg telazol in the same syringe2,3 with a maximum cumulative dose of 0.5mg/kg of 
acepromazine and 11 mg/kg telazol until the pig was in a suitable plane to administer a 
lumbosacral epidural. The lumbosacral epidural consisted of 2% lidocaine (MWI, Boise, 
ID) dosed at 2.2 mg/kg, up to maximum of 10 mL per pig.  
The KAL group received an IM injection of 0.5 mg/kg acepromazine and 5 mg/kg 
ketamine mixed in the same syringe3,4 with a maximum 1.2 mg/kg acepromazine and 33 
mg/kg ketamine until a suitable plane to administer lumbosacral epidural2,7 was reached. 
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The lumbosacral epidural (see description below) consisted of 2% lidocaine dosed at 2.2 
mg/kg, up to a maximum of 10 mL per pig.   
Between 5 and 10 minutes after the initial IM injection, pigs were assessed for 
depth of sedation based on their behavior and reflex responses. To be considered 
eligible for the joint fluid collection procedure (sufficient anesthesia), the pig must have 
been recumbent, with a negative palpebral response and negative toe withdrawal 
response. If these criteria were not met or the pig reacted to the insertion of the needle 
in the joint, then an additional dose of the applicable protocol was administered. The 
animal was then left alone, with minimal background noise and reassessed between 5 
and 15 minutes later. This was repeated until a suitable depth was attained or max dose 
was administered.  
Placement of epidural 
For groups TAL and KAL, a lumbosacral epidural was placed using an 18G X 
8.9cm spinal needle (BD™ New Jersey, USA) as described elsewhere.3,8,9 Briefly, a 25 
cm X 25 cm section on midline at the cranial aspect of the tuber coxae was shaved and 
aseptically prepared for the epidural.  The prep consisted of shaving followed by three 
steps: a chlorhexidine soap scrub, alcohol scrub, and final prep with tincture of 
chlorhexidine. Steps one and two were repeated three times. To administer the epidural, 
a veterinarian wore sterile gloves and inserted the epidural needle into the intervertebral 
disc space between lumbar vertebrae six and sacral vertebrae one. Lidocaine was 
injected into the spinal canal as previously reported.3,8,9  
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Collection of synovial fluid 
Under anesthesia, pigs were positioned in dorsal recumbency. One tarsus (all 
groups) and one carpus (groups TKX and TKA only) was selected for sampling.  An 
aseptic preparation, as described above for epidural injection, was performed on the joints 
prior to sampling.  Sterile 18G X 3.8 cm needles (Monoject BD Bioscience, San Jose, 
CA) with 12 mL syringes (Monoject BD Bioscience, San Jose, CA) were used for the 
joint fluid aspirations. Clean gloves and garments were worn.  If a needle was inserted 
into the joint, regardless if fluid was successfully collected, it was recorded and that joint 
subsequently monitored as described below.   
Anesthesia monitoring  
From the initial IM injection onwards, pigs were monitored closely until 
recovery. Heart rate, respiratory rate, rectal temperature, and depth of sedation were 
monitored at least every 15 minutes until the joint aspiration was performed, then 
monitoring changed to every 30 minutes. Heart rate was assessed using thoracic 
auscultation and breath rate was counted by observing the rib cage expansion and 
contraction. Once the pig was in sternal recumbency, vital parameters were recorded 
hourly and the pig was assessed visually approximately every 30 minutes until it was 
ambulatory.    
During the anesthesia and recovery process, the following data points were 
recorded: if sufficient plane was achieved for joint fluid aspiration (yes or no), time to 
joint sampling from first injection, time to sternal recumbency, and ambulation for pigs 
that reached sufficient plane for sampling. 
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Procedure for post-procedure observations 
After pigs were recovered and ambulatory, they were scored for lameness and 
joint swelling and then returned to their original pens. On day two, four, and seven post 
joint aspiration, pigs were re-assessed for lameness and joint swelling.  
Lameness scoring 
The gait scoring scale used from a published scoring rubric.10 Pigs were given a 
lameness score from zero to five and pigs were evaluated while standing and then while 
ambulating only. Modifications in the scoring system were used as pigs were not 
evaluated with respect to response to human presence, opening of gate, or interactions 
with penmates.  
Joint enlargement and swelling scoring 
Joint swelling scoring was performed as previously described from a published 
scoring rubric.11 In short, score 0 was no or slight joint swelling. Score 1 was soft, non-
warm swelling of the joint. Score 2 was marked soft, fluctuating enlargement of the joint 
and surroundings. Score 3 was a firm and warm periarticular swelling.11 Pigs were 
assessed visually and joints were palpated before assigning a score.  The same individuals 
performed the joint and lameness scoring for all days of the trial.    
Necropsy and sample collection 
Seven days after the joint fluid collection all animals were humanely euthanized 
for necropsy. At necropsy, all carpus and tarsus joints in which a needle penetrated were 
examined. The articular cartilage, synovial fluid, and synovial tissue were assessed 
grossly with abnormalities documented. Additional synovial tissue from each of these 
joints was collected and placed in 10% buffered formalin for histological evaluation. A 
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systematic evaluation of the internal organs and other appendicular joints was also 
performed.     
Synovial tissue scoring 
A board certified veterinary pathologist who was blinded to treatment allocation 
conducted an evaluation of the synovial tissue samples using a scoring rubric modified 
from Hagedorn-Olsen, et al.12 and published in Neto, et al.13   The score for each category 
was summed to create a composite score ranging from 0 to 15.  The scoring rubric 
encompassed two types of categories of assessment: first, categories indicative of active 
infectious processes such as neutrophil, fibrin, and hemorrhage were scored; and second, 
categories such as synovial proliferation or alterations, which encompassed noninfectious 
and chronic changes to the joint.  
Statistical analysis 
Descriptive statistics were prepared using SAS Version 9.1 (SAS Institute, Cary, 
NC).  
Results 
Anesthesia protocols 
 In Table 1, a comparison of each anesthetic protocol is presented in terms of 
successfully producing anesthesia to allow for joint aspiration, costs of anesthetic protocol 
and recovery time. All treatment groups contained at least two pigs that required additional 
dosing beyond the initial dose. All pigs in the TKX and TAL groups reached a sufficient 
plane for joint aspiration.  The recovery time for all protocols was over three hours. For 
group KAL, the first three pigs anesthetized received the maximum IM dose without 
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reaching a sufficient plane to place an epidural or conduct a joint aspiration. As such, the 
authors opted to remove the remaining three pigs from KAL group in lieu of dosing them.   
 In group TKA, pig 185 died after reaching sternal recumbency and attempting to 
stand during the recovery process. Post mortem evaluation revealed pulmonary congestion 
affecting both lungs and grossly enlarged heart with ventricular dilation.  During the 
monitoring process, pig 185 had a numerically higher heart rate and respiration rate than its 
cohorts (Table 2).  
 The heart rate, respiratory rate and rectal temperature of the pigs were measured 
regularly until the pigs could stand and the mean and range of each parameter is presented in 
Table 2. Several pigs in each treatment group required rewarming with blankets as their 
rectal temperature fell below 37°C.  
Lameness and joint swelling 
All pigs had a lameness score of 0 on day 0, 2, 4, and 7.  One pig from the TKX 
group had mild swelling (score 1) on the right carpus on day 4, which had been sampled 
on day 0. This swelling decreased to score 0 by day 7.  A second pig from the same group 
also had mild swelling (score 1) on day 2 on the left tarsus, which was sampled 
previously.  The score decreased to 0 on days 4 and 7 during the monitoring period. All 
other pigs received a joint swelling score of zero on both joints for the duration of the 
seven-day monitoring period.   
Synovial histology 
The synovium histology scoring indicated that all joints received a score of zero 
on all three categories related to acute inflammation: neutrophils, fibrin, and hemorrhage.  
There were four tarsus joints, 2 from TKX and 2 from TAL, in which there were mild, 
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non-specific changes to the synovium suggestive of a chronic, non-infectious process in 
the joint. Their cumulative synovium score ranged between 3 to 6 out of a maximum 
possible score of 15.  The gross appearance of the synovial fluid and synovium of these 
joints were within expected values for a normal joint. 
Discussion 
 Telazol, ketamine, and xylazine (TKX) was the only protocol that was consistently 
suitable for collection of joint fluid from market sized animals. The depth of anesthesia 
produced by the other protocols was insufficient to inhibit the foot withdrawal reflex, 
facilitate epidural placement or, in some cases, achieve unconsciousness. None of the pigs in 
this study were lame post procedure, nor was there evidence of iatrogenic infectious arthritis 
identified in any of the pigs.   
 There are several resources available to practitioners that recommend drug 
combinations, drug dosages and practical tips for in field anesthesia.2-5,7,14 These resources 
provide general descriptions of duration of effect, contraindications, adverse effects, and 
pharmacology. Absent from these resources is an evaluation of the utility of a specific 
protocol for a specific procedure in a specific age of pig. Without this information, there is 
increased reliance on practical experience in lieu of evidence based medicine for selection of 
anesthetic protocols for use in the field.    
 Additional considerations for field applications of TKX are that the duration of 
xylazine is relatively short (10-30 minutes) and xylazine’s analgesic, sedative and muscle 
relaxation effects are critical to balance the muscle spasticity and rigidity associated with 
ketamine in combination protocols.3,8,15,16 Thus, there is a short window for optimal joint 
aspiration procedure using TKX protocol and the practitioner needs to monitor the animal 
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closely so as to not inadvertently miss it and need to re-dose the animal, particularly if 
sampling more than one pig simultaneously. Performing a foot withdrawal test using a 
needle is an easy and non-invasive method of assessing the withdrawal reflex and suitability 
for joint aspiration.   
 During substantial recovery times as observed in this study, the potential exists for 
physiological complications which neccesitates active monitoring and veterinary 
management.  Recovery time typically decreases in smaller/young pigs due to different body 
composition and metabolism rate. For example, in two studies on telazol and xylazine in 37 
kg cross-bred pigs that assessed similar parameters to this study, the pigs reached sternal 
recumbency in 76-98 minutes and were standing at 100-130 minutes post initial 
injection.14,17 However, these papers did not use ketamine with telazol and xylazine, thus a 
direct comparison cannot be made to the recovery times published here.   
 Placement of the epidural was successful in the pigs in the TAL group but required 
additional equipment and technical skill beyond the joint aspiration. Compared to the TKX 
group, there was a longer delay between the initial IM injection, joint fluid collection and 
ultimately, recovery in the TAL group. Despite this, epidurals in swine may be useful for 
other procedures such as scrotal and inguinal hernia repair.18 
From the post mortem findings and elevated vital parameters while under 
anesthesia, it is believed that pig 185 experienced cardiac and/or respiratory 
complications that lead to death. In this study and in the field setting, it would be difficult 
to screen pigs for pre-existing conditions beyond a visual examination and thoracic 
auscultation. Since pigs have a relatively small lung capacity compared to horses and 
companion animals, knowledge of pre-existing conditions, such as previous bouts of 
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pneumonia, would be important for selecting good candidates for anesthesia and 
subsequent antemortem joint aspirations.8 Additionally, pig 185 was in the TKA group 
which received a larger dose of acepromazine than other groups. Acepromazine is known 
for its hypotensive effects that may have negatively affected cardiac output in this pig.19 
For this reason, in addition to recovery time, it is not advised that practitioners use TKA 
in the field for market weight hogs.  
The mean values for individual pig heart rate, respiration rate, and temperature 
were generally elevated compared to normal values for finishers reported in Anderson 
and St. Jean.3 Also, within each of the treatment groups, there was variability in vital 
parameters between individual pigs. For example, mean heart rate in the TKX group 
ranged between 82 and 116 beats per minute. Information about normal vital parameters 
for commercial pigs in field conditions is limited. Published values for vital parameter 
information under specific anesthetic regimes in the field are not available. Thus, Table 2 
provides information for practitioners on the vital parameter values and variability they 
may encounter while performing field anesthesia in finisher pigs.   
 This study emphasizes the use of tools readily available to practitioners in the field to 
monitor vital parameters. This is unique from other anesthetic evaluation and comparison 
studies in which there is additional monitoring performed including blood pressure, arterial 
blood gases, and blood biochemistry.14,17,20 In those studies, expanded monitoring was 
critical to collect the data required to compare the physiological effects of different protocols 
which served as the primary objective of the research.  The present study focused on the 
ability of anesthetic protocols to provide appropriate conditions for efficacious completion 
of a diagnostic task.  
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TKX performed well during this antemortem procedure and allowed for the 
successful collection of joint fluid and prompt recovery post procedure. An anesthetic 
protocol for antemortem joint taps that is applicable to commercial settings and cost 
effective is a valuable tool to practitioners for diagnostic investigations of lameness. The 
antemortem technique allows practitioners to increase their diagnostic sample size, 
monitor treatment success in sampled pigs, and can complement post mortem 
examinations in affected herds. Veterinary practitioners must carefully consider the local, 
state, and federal regulatory consequences and current rules or guidance before utilizing 
any anesthetic protocol in the field. 
Implications 
TKX was the best overall anesthetic protocol for antemortem joint fluid collection 
in this trial. Veterinary practitioners must carefully consider the local, state, and federal 
regulatory consequences and current rules or guidance before utilizing any anesthetic 
protocol in the field. Antemortem joint fluid collection was not associated with 
significant joint tissue damage; therefore, it has potential as a useful diagnostic tool for 
infectious arthritis.  
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Table 1. Comparison of four anesthetic protocols with respect to cost, procedure success and recovery times. 
Group information for all pigs TKX KAL TAL TKA 
Number of pigs 6 3* 6 6 
Mean body weight in kilograms (SD†) 83.1 (12.7) 92.1 (2.7) 82.2 (6.4) 90.1 (10.7) 
Number of animals for which sufficient surgical plane 
was achieved to allow for joint aspiration (%) 6 (100%) 1 (33%) 6§ (100%) 2¶ (33%) 
Number of pigs requiring at least one additional dose 
(%) 2 (33%) 3 (100%) 3 (50%) 6 (100%) 
Number of pigs that reached maximum dosage 0 (0%) 3 (100%) 0 (0%) 2 (33%) 
Mean cost of anesthesia protocol (SD) $24.98 
(4.16) 
$22.37 
(0.82) 
$38.96 
(4.65) 
$50.99 
(3.65) 
Procedure and recovery time for pigs that reached 
sufficient surgical plane for joint aspiration     
Mean time to joint aspiration from first injection‡ in 
minutes (SD) 13 (9) 74 (-¶) 40 (7) 82 (2) 
Mean time to sternal‡ in minutes (SD) 125 (26) 151 (-¶) 198 (28) 363 (258) 
Mean time to ambulatory‡ in minutes (SD) 266 (73) 317 (-¶) 378 (79) 267 (-**) 
*As the first three pigs anesthetized did not reach a sufficient plan to place an epidural or conduct joint aspiration, the 
remaining three pigs in the group were not dosed and were removed from the study. 
†SD refers to standard deviation 
‡ for pigs that reached sufficient surgical plane for sampling 
§in one pig, the joint was sampled but fluid was not collected 
¶n=1 
**Pig died after achieving sternal recumbency 
TKX: telazol, ketamine and xylazine; KAL: ketamine and acepromazine with lidocaine epidural; TAL: telazol and 
acepromazine with lidocaine epidural; TKA: telazol, ketamine and acepromazine.   
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Table 2.  Mean, minimum, and maximum heart rate, respiratory rate, rectal 
temperature of pigs for four injectable anesthetic protocols. Each parameter was 
measured until pigs could stand. 
 
Pig 
Heart rate 
(beats/min) 
Respiratory rate 
(breaths/min) 
Rectal temperature 
(°C) 
  Mean Low High Mean Low High Mean Low High 
TKX 
178 116 104 140 34 28 44 38.9 38.0 39.9 
179 98 88 128 43 24 60 38.7 37.8 39.5 
180 111 90 140 39 28 52 39.1 38.5 39.7 
181 101 80 120 38 24 52 38.1 37.3 38.9 
182 96 84 112 41 20 76 38.2 37.5 39.6 
183 82 64 100 50 32 80 37.7 36.7 38.6 
KAL 
190 115 68 148 35 24 48 38.2 37.6 39.0 
191 117 72 148 45 44 48 37.3 36.6 38.3 
192 89 52 128 34 28 44 37.4 36.4 38.4 
TAL 
193 121 96 160 40 28 52 36.7 35.9 38.9 
194 109 64 140 41 28 64 37.9 36.7 39.6 
195 119 104 132 44 24 76 37.3 36.6 39.2 
196 108 72 120 34 20 48 36.6 36.0 37.7 
197 122 72 160 57 40 80 37.8 36.2 39.4 
198 90 72 108 37 28 60 36.7 35.2 38.8 
TKA 
184 105 56 128 30 28 40 37.9 36.8 39.0 
185* 160 120 200 55 36 84 38.2 37.0 39.3 
186 122 60 160 39 24 60 38.2 37.5 39.1 
187 96 78 116 53 36 78 38.0 36.6 39.6 
188 100 80 140 29 18 44 38.2 37.4 39.5 
189 100 80 120 42 36 44 37.3 36.5 38.5 
*Pig number 185 died before it was observed to have stood 
TKX: telazol, ketamine and xylazine; KAL: ketamine and acepromazine with 
lidocaine epidural; TAL: telazol and acepromazine with lidocaine epidural; TKA: 
telazol, ketamine, and acepromazine.   
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Abstract 
Objectives 
Cytological evaluation and fluid analysis of synovial fluid is a common diagnostic 
process used in equine and companion animal medicine to diagnosis joint disease. Diagnostic 
tests for lameness in swine are limited and there are no reference intervals available for swine 
synovial fluids.  
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The objective of this study was to create reference intervals for total nucleated cell 
count, total protein, pH, red blood cell count, percentage of neutrophils, lymphocytes, and 
large mononuclear cells for the carpus and the tarsus joints in healthy swine.   
Animals  
Fifty-four healthy finishing pigs that did not display lameness or gross joint swelling.  
Procedures  
Pigs were anesthetized and synovial fluid samples were collected from the carpus and 
tarsus for cytologic evaluation, fluid analysis, and culture. Animals were euthanized after 
collection and synovial tissue samples were collected for histologic assessment.  
Results  
Thirty-seven (37) tarsus and 46 carpus samples met inclusion criteria of sufficient 
volume, no gross blood contamination, negative by culture and polymerase chain reaction for 
common swine joint pathogens and normal synovial tissue histology. The upper reference 
limit for percentage neutrophils for the carpus was 46.5% and 33.7% for tarsal samples. The 
upper reference limit of total protein for carpal fluid samples was 3.6g/dL and 3.6g/dL for 
tarsal samples. Both anatomical locations had between 92% and 95% large mononuclear 
cells at their upper reference limit.  
Conclusions and clinical relevance  
The novel synovial fluid cytologic evaluation and fluid analysis reference intervals 
provided by this study aid diagnostic investigations of swine lameness and arthritis.  
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Abbreviations 
IM intramuscular  
ISU VDL Iowa State University Veterinary Diagnostic Laboratory  
LMC large mononuclear cells  
MHR Mycoplasma hyorhinis  
MHS Mycoplasma hyosynoviae  
PCR polymerase chain reaction  
TNCC total nucleated cell count  
TP Total protein 
RBCC red blood cell count  
%NEUTS neutrophils 
%LYMPHS percentage of lymphocytes  
%LMC percentage of large mononuclear cells 
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Introduction 
Infectious and non-infectious lameness issues of growing swine are a welfare concern 
and can increase production costs. Lameness diagnosis has historically relied upon gross 
changes coupled with postmortem synovial fluid culture and PCR testing.1 This strategy 
requires the euthanasia of affected pigs, limiting sample size selection and preventing follow-
up investigation of the effect of treatments post-diagnosis. Thus, antemortem diagnostic 
assessments of synovial fluid that are applicable to a broad range of lameness agents would 
be useful. Diagnosing the cause of lameness using an antemortem sample collection 
technique would afford practitioners the opportunity to monitor treatment success of 
interventions.   
In equine and canine medicine, cytologic evaluation and fluid analysis of synovial 
fluid is a core antemortem diagnostic test for multiple types of arthritis.2,3 Routine synovial 
fluid analysis encompasses fluid analysis and cytologic evaluation, and reports fluid pH, total 
protein (TP), and differential nucleated cell percentages. Combined with PCR and culture, 
cytologic evaluation and fluid analysis could be key diagnostic tools for swine joint fluid.   
Published cytologic evaluation and fluid analysis values for swine joint fluid are currently 
very limited.  
The objective of this study was to report cytologic evaluation and fluid analysis 
reference intervals from clinically healthy pigs for total nucleated cell count (TNCC), TP, 
pH, red blood cell count (RBCC), percentage of neutrophils (%NEUTS), percentage of 
lymphocytes (%LYMPHS), and percentage of large mononuclear cells (%LMC) for the 
carpus and the tarsus joint. 
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Materials and methods 
Sample size 
Two studies were conducted to create the reference intervals. Both trials were 
approved through the Iowa State University Institutional Animal Care and Use Committee. 
The American Society of Veterinary Clinical Pathologists establishes a minimum sample size 
of >20 animals to report reference intervals.4 It was anticipated that an inadequate fluid 
volume would be collected or blood contamination in the sample would occur frequently 
when collecting joint fluid samples, thus the sample size of 54 pigs was used and the study 
was divided and executed at two different time periods (trial 1 and 2).  
Animals and Housing 
Thirty healthy, non-lame pigs (trial 1) and 24 healthy, non-lame pigs (trial 2) were 
weighed and moved into individual pens during the studies. Both groups were commercial, 
crossbred finisher pigs (16 to 18 weeks of age) that were housed in the same continuous 
flow finisher barn before enrollment. The pens were rectangular, partially slatted, with 15 
to 20 pigs per pen and the stocking density was approximately 9 ft2 per pig. The pigs were 
owned and supplied by an Iowa State University swine farm. Pigs were procured from a 
source with no reported clinical history of lameness. Trials 1 and 2 were separated by 
approximately six weeks. Both groups were an equal mix of barrows and gilts. All pigs 
were fed ad libitum commercial finisher feed without antibiotics for the duration of the 
trial. The diets met all swine nutrition National Research Council requirements.5 At 
selection, pigs were given a physical exam by a veterinarian, which included palpation of 
joints, and pigs had to be free of clinical signs to enter the trial. Pigs were assessed while 
standing and during locomotion prior to selection.  
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Lameness and joint scoring 
Upon selection, pigs were given a lameness score and joint swelling score. The 
scoring system used was previously reported.6 To be included in the study, pigs must have 
scored a zero on both lameness and gross swelling score.6  Briefly, for the lameness scoring, a 
score of zero indicated that the animal moved freely and used all four limbs evenly. The joint 
swelling score was modifiied slightly for this study, as a score of zero for the joint swelling 
scale indicated no swelling.  
Anesthesia treatment groups  
To achieve general anesthesia, all pigs were given intramuscular anesthetic agents 
and were under general anesthesia during collection of joint fluid. Pigs were not intubated. 
Trial 1 pigs received an IM injection of tiletamine hydrochloride and zolazepam 
hydrochloridea (4.4mg/kg), ketamineb (2.2mg/kg), and xylazinec (4.4mg/kg) combined in 
the same syringe. Trial 2 pigs were randomly allocated to one of four treatment groups. 
Group one received the same anesthetic protocol as trial 1 pigs. Group two received 0.03 
mg/kg of acepromazined, 2.2 mg/kg of ketamineb, and 4.4 mg/kg of tiletamine 
hydrochloride and zolazepam hydrochloridea given IM. Group three received an IM 
injection of 0.3 mg/kg of acepromazined and 4.4 mg/kg of tiletamine hydrochloride and 
zolazepam hydrochloridea all from the same syringe and an aseptically placed epidural. The 
lumbosacral epidural consisted of 2% lidocainee dosed at 2.2 mg/kg up to 10 mL. Group 
four received an IM injection of 0.5 mg/kg of acepromazined and 5 mg/kg of ketamineb all 
from the same syringe and an aseptically placed epidural. The lumbosacral epidural 
consisted of 2% lidocainee dosed at 2.2 mg/kg up to 10 mL. Individual pig weights were 
used to calculate anesthetic dosages. The anesthetic treatment groups in trial 2 were part of 
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a separate study to assess the quality of anesthetic procedures and results from this analysis 
are to be published elsewhere.  
To be considered eligible for the joint fluid collection procedure, the pig must have 
been fully anesthetized, recumbent, and have a negative palpebral response and toe 
withdrawal response. From the anesthetic injection onwards, pigs were monitored closely. 
Heart rate, respiratory rate, temperature, and depth of sedation were monitored at least 
every 10 minutes while the pig was anesthetized and every 30 minutes to one hour during 
the recovery process.   
Antemortem centesis 
Once anesthetized, pigs were positioned in dorsal recumbency. One tarsus and 
carpus per pig was prepared by shaving followed by three steps: a chlorhexidine soap 
scrub, alcohol scrub, and final prep with tincture of chlorhexidine. Steps one and two were 
repeated to ensure asepsis of the centesis site. Once the joints were prepared for sampling, 
the joint was dried using sterile gauze and a sterile adhesive drape was applied (trial 1 
only). In Trial 2, the joints were left to air dry for approximately 45 seconds.  
To aspirate the joint fluid, an 18G 1.5 inch needle on a 12 cc sterile syringe was 
inserted into the dorso-lateral aspect of the joint and negative pressure was used to aspirate 
the joint fluid into the syringe. Clean garments and clean gloves were worn for sampling. A 
gross description including color, clarity, and blood contamination was recorded for each 
joint fluid sample. One veterinarian with previous experience with swine joint fluid 
aspiration collected all the joint fluid samples for the entire study. 
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Postmortem centesis 
If two suitable joint fluid samples (one from the carpus and one from tarsus) were 
not collected antemortem for a pig in either trial due to insufficient anesthetic plane, 
insufficient volume, or gross blood contamination, the contralateral joint was sampled 
postmortem using the same methods as described above.  
Sample handling 
The minimum volume of joint fluid required to complete all the tests was 0.5 mL. If 
this was not attained, the sample was discarded.  Half of the volume of joint fluid collected 
was immediately placed into a 2 mL EDTA tubef, agitated and submitted for fluid analysis 
and cytologic evaluation within 8 hours of collection. The remaining aliquot for each joint 
was pooled by pig at the lab and submitted for aerobic bacterial culture, MHS PCR, and 
MHR PCR at the ISU VDL. Samples were stored on ice within two minutes of sample 
collection until submission to the diagnostic laboratory for analysis. 
Euthanasia and trial end point 
For trial 1 pigs, once antemortem sampling was completed, pigs were euthanized by 
penetrating captive bolt and exsanguinated. Insensibility was determined by absent corneal 
reflex and death confirmed by absence of respiration and heartbeat. For trial 2, pigs were 
recovered from anesthesia and monitored for seven days then euthanized using the same 
procedures described above.  
Samples collected at necropsy 
A systematic postmortem was completed for each pig including the collection of 
tonsils for testing of DNA MHS and DNA by MHR PCR assays (trial 1 only) and clinical 
examination of joints. Tonsils were not collected in trial 2 due to the very low prevalence 
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of MHS and MHR found in trial 1.  Identification and recording of gross abnormalities to 
synovial fluid, synovium, and cartilage was completed for the left and right 
humeroscapular, radial-humeral, radial meta carpal, coxofemoral, tibiofemoral, metatarsal 
and tarsocrural joints. If gross abnormalities were identified in a joint, the corresponding 
joint fluid and synovial tissue were submitted for diagnostic testing including histology, 
culture and PCR as described above. Internal organ evaluation was performed and fresh 
and fixed tissue(s) were submitted for diagnostic testing including histology, molecular 
testing, and culture as per discretion of pathologist if gross abnormalities were identified.  
Oral fluids 
Oral fluids were collected from pens containing pigs enrolled in either trial two 
weeks before the commencement of the trial, and at the end of the trial using clean cotton 
rope as described in a previous study.7 The oral fluids were submitted for MHR and MHS 
PCR.  
Mycoplasma hyosynoviae and Mycoplasma hyorhinis sample processing, DNA 
extraction, and PCR 
For oral fluids, joint fluid, and tonsil tissue, DNA extraction was performed using a 
nucleic acid isolate kitg and a magnetic particle processor h as per the manufacturers’ 
instructions and as described previously.8 Joint fluid was processed using a homogenizeri for 
five minutes at maximum speed as an additional step during the extraction process. The 
carpus and tarsus sample from each pig was pooled for the MHS and MHR PCR. Tonsils 
were processed as per standard operating protocol at the ISU VDL. By using forceps and 
scissors, tonsil was weighed and subsequently minced/ground prior to placing into a 
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stomacher bag and processed as a 10% homogenate. Oral fluids were processed using a high-
volume modified lysis procedure.9    
The procedures for DNA amplification and detection for MHS and MHR used in this 
study are provided in detail in another study.8  
Culture  
Joint samples submitted for routine culture in the ISU VDL were setup following the 
standard protocol. The carpal and tarsal sample from each pig was pooled for the culture. 
This setup included aerobic and anaerobic conditions, the inclusion of Staphylococcus aureus 
nurse for organisms requiring nicotinamide adenine dinucleotide, and selective media 
consisting of brilliant green agar for Salmonella sp. isolation. No additional selective or non-
selective enrichment was performed on the samples and plates were incubated for a 
minimum of 48 hour prior to reporting no growth. The samples were considered to have “no 
significant growth” if non-pathogenic organisms were isolated. The significance of the 
growth was determined by the veterinary pathologist on each case.   
Histopathology  
After collecting the joint fluid the joint was then opened to obtain a sample of 
synovium which was immediately placed in 10% buffered formalin solution. 
Histopathology scoring was performed by a board certified veterinary pathologist who was 
blinded to treatment groups. A scoring rubric was modified from another study on infectious 
arthritis and included evaluation of synovial proliferation, synovial alteration, inflammation, 
edema, neutrophil infiltration, presence or absence of fibrin, and hemorrhage. 10 Abnormal 
synovial histology was defined as having a proliferation, alteration, inflammation, or edema 
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score of 2 or greater (moderate changes) or neutrophil infiltration or presence of fibrin or 
hemorrhage.10  
Cytologic evaluation and fluid analysis  
The cytologic evaluation and fluid analysis procedures for joint fluids submitted in 
EDTAf are as follows. The sample was checked for blood clots in the EDTAf tube visually 
and this was a dichotomous outcome (yes/no to blood clot). A TNCC and RBCC was 
performed using a hematology analyzer. j Hyaluronidase was added to the sample before the 
cell counts.11 Color and clarity was reported. Samples were discarded and were not included 
in the reference interval if they were red due to gross hemo-contamination. Clarity was 
considered acceptable if the sample was clear, slightly hazy, or cloudy. Samples with fibrin, 
blood clots, or purulent material were rejected. The pH was measured and recorded using pH 
paperk. Total protein was measured with a digital refractometer l. If a sample was too turbid 
to read, a hematocrit tube was spun down and the percent total solid was read from the 
supernatant. If volume was <0.5 mL, the TP measurement was not valid and it was recorded 
as insufficient volume.  
For cytologic evaluation slide preparation a direct smear was made with a camel hair 
brush.  A cytospin sample was made using 100 µl of synovial fluid spun at 72 g for 10 
minutes.m The direct and cytospin samples were analyzed by a board certified clinical 
pathologist and a 300-cell differential cell count were performed. The fluid analysis and 
cytologic evaluation was performed individually on each tarsus and carpal sample per pig.  
A description of the LMC morphology used for the cytologic evaluation was as follows: in a 
normal joint, the large mononuclear cells in fluid are typically round-shaped cells with a 
moderate nuclear:cytoplasmic ratio.  They often contain round, centrally placed nuclei with 
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dense chromatin; their cytoplasm is basophilic and lacks vacuolization.  Morphologically, 
both quiescent macrophages and synoviocytes may have this appearance and thus 
the encompassing term large mononuclear cells is used to categorize them. 
Summary of inclusion criteria 
For the individual animal to be included in the study, the pig must have been healthy, 
non-lame with no grossly visible swelling of joints. Additionally, for trial 1, the tonsil PCR 
for MHS and MHR must be negative. For an individual joint fluid sample to be included in 
the study, the fluid must have been within the acceptable clarity and color stipulations 
described above. The fluid sample must have no growth on aerobic culture and be PCR 
negative for MHS and MHR. Synovium histology from the joint must have been free from 
histopathologic changes indicative of active joint disease. At least 0.5 mL of volume was 
required for the complete fluid analysis.  
Statistical Analysis 
 Reference intervals were established for TNCC, TP, pH, RBCC, %NEUTS, 
%LYMPHS, and %LMC for the carpus and tarsus joints. Reference intervals were established 
in accordance with the published guidelines for reference interval determination by the 
American Society of Veterinary Clinical Pathologists.4 Data was evaluated with the D’Agostino 
and Pearson omnibus test to determine normality; data was assessed with the Tukey test for 
identification and removal of statistical outliers only. Suspect outliers were not removed. For 
parametric variables, robust methodology on native data was used to calculate the upper and 
lower reference limits, and a bootstrap method was used to calculate the 90% confidence 
intervals around these limits.4 For nonparametric variables, a Box-Cox transformation was first 
performed and then robust methodology was used to calculate the upper and lower reference 
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limits, and a bootstrap method was used to calculate the 90% confidence intervals around these 
limits.4,12  To assess the contribution of blood contamination to %NEUTS in the sample, a 
correlation analysis was performed between RBCC and %NEUTS for both carpal and tarsal 
samples. If the distributions of RBCC and %NEUTS were normal, then a Pearson correlation 
coefficient was calculated. If the distributions were skewed, then a Spearman correlation 
coefficient was calculated.  
Additionally, for each joint, the assessed variables were evaluated to determine if 
differences existed between antemortem and postmortem collected samples. For parametric 
variables, a simple T-test was used to compare the means of the antemortem and postmortem 
samples; a Wilcoxon rank sum test was used for nonparametric variables to compare 
medians.  Statistical significance was set at p < 0.05.  Reference interval determination and 
statistical comparisons were performed using graphing and reference interval analysis 
software packages.n,o 
Results 
Oral fluids  
 Oral fluid testing for MHS and MHR from pens holding pigs used in trial 1 and 2 were 
negative two weeks prior to the start and at the end of both trials.  
Selection of individual pigs 
 There were eight pigs that were rejected at physical exam for the following reasons: 
umbilical hernia (3), diarrhea (2), conjunctivitis (3). There were four pigs excluded due to joint 
swelling and no pigs were excluded for lameness. These four pigs were not lame and palpation 
revealed very slight swelling of a bursa on the lateral aspect of the tarsus and thus these pigs 
were excluded. 
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Inclusion and exclusion of joint samples 
 There was a total of 50 tarsus and 53 carpus joint fluid samples from 54 finisher hogs 
collected antemortem or immediately after euthanasia. Fluid samples without major gross blood 
contamination could not be attained ante or postmortem from four hogs (tarsus) and one hog 
(carpus). The mean weight of pigs (standard deviation) was 130.3 kg (8.2 kg). A separate 
reference interval database was created for carpus and tarsus samples. Six samples, representing 
carpus and tarsus samples from three animals, were excluded due to tonsil positive PCR results 
for MHR. All tonsils were negative for MHS using PCR. The remaining samples were all 
negative using PCR for MHS and MHR. Ten samples were excluded due to mild abnormalities 
in synovium histology. Of these ten samples, seven were tarsus samples and three were carpus 
samples. Four samples, (three tarsus and one carpus) were excluded due to positive bacterial 
culture results. Culture results identified Staphylococcus epidermis and Acinetobacter johnsonii, 
and thereby were considered skin contaminants13.  
 Fluid analysis was unable to calculate TNCC, RBCC, TP, and pH data due to clotting in 
the EDTA tube for seven tarsus and three carpus samples. There was one carpus sample where 
TP and pH could not be determined due insufficient quantity of fluid. For the tarsus samples, 
insufficient sample volume prevented the determination of TP in two samples and pH in one.  
No visible osteochondrosis lesions were identified in carpal and tarsus joints used for the 
reference intervals. In the elbow of some pigs (11 total; 20%) there were small (<1 cm wide by 
<3 mm deep) linear, irregular depressions or folds in the cartilage that were suspect of 
osteochondrosis manifesta. Synovial fluid and synovial tissue collected from these joints 
revealed no bacterial pathogens and mild or no inflammatory changes to the synovium. None of 
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the pigs sampled were clinically lame, had abnormal gaits, or had grossly visible joint 
enlargements.  
Antemortem and post mortem samples 
 Out of the samples that met eligibility criteria, for the tarsus, there were 23 antemortem 
and 14 postmortem samples. For the carpus, 23 samples were collected antemortem and 23 were 
collected postmortem. Group three in trial 2 was sampled exclusively postmortem due to 
ineffectiveness of the ketamine and acepromazine to achieve sufficient anesthetic plane for 
synovial centesis. There were no differences in antemortem and postmortem samples for the 
carpal samples for any of the cytologic evaluation and fluid analysis parameters and these two 
datasets were combined.  For the tarsus samples, the antemortem samples had higher RBCC 
relative to the postmortem samples. The main determinant of RBCC is the sample collection 
process itself. Red blood cell count generally reflects blood contamination as opposed to 
pathological changes related to joint inflammation. For this reason, antemortem and postmortem 
samples were combined for the tarsal samples and used to create the reference intervals.   
Fluid analysis and cytologic evaluation 
 Carpal and tarsal fluid analysis and cytologic evaluation reference variables of healthy 
pigs are listed in Tables 1 and 2. The final number of samples used to establish reference 
intervals for each cytologic evaluation and fluid analysis variable is available in Tables 1 and 2. 
For the tarsal samples, all but one sample was slightly hazy/cloudy. In terms of color, the tarsal 
samples were light pink or red (n=27), light yellow (n=5), colorless (n=4), or light orange (n=1). 
The carpus samples were all slightly hazy/cloudy and the colors reported were as follows: light 
pink or red (n=22), light yellow (n=13), colorless (n=9), or light orange (n=2).  
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 For both carpal and tarsal samples, the distribution of RBCC and %NEUTS was skewed 
to the right and the Spearman correlation coefficient was used to assess correlation. For carpus 
samples, the Spearman correlation coefficient was 0.6346 (p-value <0.0001) indicating 
moderate correlation. For tarsal samples, the Spearman correlation coefficient was 0.2954 (p-
value 0.1130) indicating there was weak or no correlation. 
Necropsy results 
 At necropsy, minor gross lesions in internal organs were identified in most of the pigs 
(83%) from both trials. The most common lesion was minor lung edema, with atelectasis or 
consolidation (<15% of each lung affected).  For all gross lesions, diagnostic investigation did 
not reveal an active infectious process contributing to gross pathology and none of the pigs 
showed clinical signs such as coughing, nasal discharge, or diarrhea.  The lung consolation was 
attributed to previous infectious insult, related to blood pooling postmortem or due to the cause 
of death (penetrating captive bolt).    
Discussion 
 This study produced reference intervals from non-lame commercial finisher pigs for 
carpal and tarsal synovial fluid cytologic evaluation. There is only one other study to the 
author’s knowledge that has published cytologic evaluation and fluid analysis variables for 
swine synovial fluid. It reported pH, specify gravity, glucose per 100mL, TP, RBCC, TNCC, 
and differential white cell percentages for five normal adult pigs.14 The sampled joint and joint 
fluid was grossly normal and sterile based on culture although it is unclear which joints were 
sampled. The average TP reported was 3.9g/dL, TNCC was 220 cells/µL, and RBCC was 0.005 
x 10^6 cells/µL.14 These averages fall within the reference intervals reported in this study for 
carpus and tarsus, except for TP which was slightly above the determined upper 90% confidence 
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interval for the carpus. For the differential cell percentages, reported %LYMPHS were higher 
(mean: 49%) than reported in this study for the carpus but not for the tarsus. Other differential 
cells percentages appeared to be within the intervals reported here.14  
 Compared to horses, it appears that the upper reference limit for TNCC and TP is higher 
for swine. Reference intervals for horses reported TNCC <1000cells/µL and TP <2.0g/dL as 
normal; however, for swine, <4000cells/µL and <3.90g/dL seems more appropriate based on the 
values we present here.2,15 In dogs and cats, TNCC is generally <1000-3000cells/µl (dogs) and 
<1100cell/µl (cats).3,16 For canine synovial fluid, normal TP levels, as with all other variables 
vary by laboratory but are generally between 1.8 to 4.8g/dl, with <2.5g/dl considered normal.3 
In this study, the pH lower and upper reference limits were 6.1-7.2 for carpus and 6.2-7.0 for 
tarsus which was lower than pH ranges published for horses and companion animals. It should 
be noted that the lower limit of detection for pH in this study was 6.0. For horses, pH of 7.30+/- 
0.06 is considered normal.2,1 For dogs and cats, a pH of 7.2 to 7.4 is considered normal.3 
 Normal joint fluid should have low cellularity and guidelines from other species report 
<80-90% LMC, <10% neutrophils, and <20% lymphocytes.2,3,17 In horses and dogs, neutrophils 
make up approximately <10-12% of the differential cell percentages.3,17-19 In cats, the percent 
neutrophils that is considered normal is less than 39%, which is closer to values identified for 
hogs in this study (<46% for carpus and <33% for tarsal samples).17  As with other species, 
LMC are also the predominant cell type in swine synovial fluid. There is a large range between 
the lower and upper reference limit for all the differential cell percentages in Tables 1 and 2, 
particularly for LMC.  
 There was some correlation between RBCC and %NEUTS for the carpus sample set 
which may indicate that a portion of neutrophils in each sample were due to non-grossly visible 
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blood contamination. For the tarsal samples, however, it does not appear that %NEUTS were 
contributed by sampling hemorrhage due to the weak correlation between RBCC and %NEUTS.  
 During infectious and degenerative pathological processes, morphological and 
percentage changes to the LMCs, neutrophils and lymphocytes can be observed. Cytologic 
evaluation and fluid analysis on synovial fluid can be used to identify normal joints, 
degenerative joint disease, acute injury and inflammatory joint disease, which can be infectious 
or immune mediated.2,3,18,20 Currently, there are no other experimental studies describing the 
changes in synovial cytologic evaluation and fluid analysis associated with various swine-
specific joint pathogens and extrapolation from other species would be necessary to interpret 
changes in swine synovial fluid.  
 There are several variables which were not controlled for in this study and there is 
limited information on how these variables may impact cytologic evaluation and fluid analysis 
outcomes on normal swine synovial fluid. The pigs in these studies were crossbred, raised on 
partially slatted floors, and were close to market weight.  Differences between genetic lines, age 
groups, stocking density, structural conformation, housing, and nutrition may impact cytologic 
evaluation and fluid analysis variables for synovial fluid.  
 An additional consideration is that mild osteochondrosis manifesta lesions were 
observed in the forelimbs of some pigs. None of the joints included in the reference intervals 
had osteochondrosis manifesta. Osteochondrosis can cause changes to cytologic evaluation and 
fluid analysis results in circumstances where it causes degenerative joint disease and 
osteoarthritis.20 Lesions consistent with osteoarthritis or degenerative joint disease were not 
identified in any joints.   
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 The creation of a reference interval dataset for synovial fluid from non-lame, healthy 
finisher pigs provides a novel diagnostic tool to practitioners and production companies. In 
equine and canine medicine, synovial fluid cytologic evaluation and fluid analysis is a core 
diagnostic test for lameness and arthritis. For horses, it is considered an extremely useful tool 
for the diagnosis of septic arthritis.2,21 Coupled with culture, molecular testing for mycoplasma 
species, and histology on the joint tissue, swine cytologic evaluation and fluid analysis helps 
complete the diagnostic picture.2 Due to the transient nature of many infectious arthritis agents, 
multiple pieces of evidence indicative of infectious agents are critical for an accurate diagnosis. 
This complete diagnostic picture allows veterinarians to more confidently and accurately create 
a diagnostic and treatment plan for a given patient. Improved diagnostic and treatment plans are 
a direct benefit to pigs and caretakers alike. Moreover, these novel ante mortem reference 
intervals for synovial fluids allows veterinarians to document the effect of health interventions 
in lame pig populations without the need to euthanize pigs. 
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Footnotes 
a Telazol, tiletamine HCl and zolazepam HCl injection, (100mg/mL when reconstituted)  
Zoetis, Kalamazoo, MI  
b Ketamine HCL injection (100mg/mL) Zoetis, Kalamazoo, MI 
cXylazine injection (100mg/mL) VetOne/Akorn, Inc. Lake Forest, IL 
dAcepromazine Maleate injection (10mg/mL), VetOne/Akorn, Inc. Lake Forest, IL 
e2% Lidocaine, MWI, Boise, ID. 
fBD Bioscience, San Jose, CA 
gMagMAX™ Total Nucleic Acid Isolation Kit, Thermo Fisher Scientific; Waltham, MA  
hKingFisher® 96 magnetic particle processor, Thermo Fisher Scientific; Waltham, MA 
iBioSpec Bead Beater, Bartlesville, OK 
jADVIA 2120, Siemens, Malvern, PA. 
kHydrion pH 6.0 – 8.0, MicroEssentialLab, Brooklyn, NY 
1Clinic-Check refractometer, Reichert Technologies, Depew, NY 
mCytopsin 4, Thermo Scientific, Waltham, MA 
nGraphPad Software, Inc., La Jolla, CA 
oReference Value Advisor, Biostatistiques Ecoli Nationale Vétérinaires de Toulouse, 
Toulouse, France 
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Table 1. Reference intervals for clinical pathology variables from carpal joint fluid samples from normal, non-lame 
commercial finishing hogs. 
Parameter  
TNCC* 
(cells/µL) 
Protein 
(g/dL) pH 
RBCC† 
(1x10^6 
RBC/µL) 
Neutrophil 
% 
Lymphocyte 
%  
LMC‡ 
% 
Lower limit of reference interval  199.4 2.0 6.1 0.002 0.3 2.6 27.5 
Upper limit of reference interval  3280.7 3.6 7.2 0.3 46.5 40.6 92.0 
 
90% CI for lower limit  186 1.9 6.0 0.002 0.1 0 0.5 
 228.4 2.2 6.2 0.003 0.6 5.9 43.0 
90% CI for upper limit  1977.3 3.4 7.1 0.03 32.0 35.9 88.5 
 5164.8 3.8 7.2 0.5 66.0 44.8 95.0 
Gaussian distribution of data (Y/N)  No Yes No No No Yes No 
Number of samples  43 42 42 43 46 46 46 
Number of sample for reference 
intervals  43 42 42 43 46 46 46 
Outliers removed  0 0 0 0 0 0 0 
Type of interval  
Box-Cox 
Robust Robust 
Box-Cox 
Robust 
Box-Cox 
Robust 
Box-Cox 
Robust Robust 
Box-
Cox 
Robust 
*Total nucleated cell count 
†Red blood cell count 
‡Large mononuclear cell 
 
 
  
75 
76 
 
 
Table 2. Reference intervals for clinical pathology variables from tarsal joint fluid samples from normal, non-lame 
commercial finishing hogs. 
Parameter  
TNCC* 
(cells/µL) 
Protein 
(g/dL) pH 
RBCC† 
(1x10^6 
RBC/µL) 
Neutrophil 
% 
Lymphocyte 
% 
LMC‡ 
% 
Lower limit of reference 
interval  189.2 1.3 6.2 0 0.7 0.5 24.4 
Upper limit of reference 
interval  2367.6 3.6 7.0 0.1 33.7 56.3 95.3 
 
90% CI for lower limit  154.8 1.1 6.1 0 0.2 0 15.7 
 235.8 1.5 6.2 0.001 1.9 7.4 33.7 
90% CI for upper limit  1488.7 3.1 6.9 0.05 26.2 48.4 87.5 
 4094 4.0 7.0 0.2 41.8 63.9 104.8 
Gaussian distribution of data 
(Y/N)  No No No No No Yes Yes 
Number of samples  30 28 29 30 37 37 37 
Number of sample for 
reference intervals  28 28 28 27 36 37 37 
Outliers removed  2 0 1 3 1 0 0 
Type of interval  
Box-Cox 
Robust 
Box-Cox 
Robust 
Box-Cox 
Robust 
Box-Cox 
Robust 
Box-Cox 
Robust Robust Robust 
*Total nucleated cell count 
†Red blood cell count 
‡Large mononuclear cell 
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Abstract 
The objectives of this study were to determine the concentration of tylvalosin (TVN) 
and its metabolite, 3-O-acetyltylosin (3AT) in the synovial fluid of growing pigs when 
administered as a single bolus by oral gavage at target doses of 50 mg/kg (Trial 1) and 
5mg/kg (Trial 2).  TVN is a water-soluble macrolide antimicrobial used in swine production. 
The stability of the drug in synovial fluid samples stored at -70°C up to 28 days was also 
evaluated in Trial 2. In Trial 1, eight pigs were randomly assigned to one of eight time points 
for euthanasia and synovial fluid collection: 0, 1, 2, 3, 4, 6, 9, 12 hours post-gavage. For Trial 
2, twenty-four pigs were randomly allocated to one terminal collection time point at 0, 2, 4, 
6, 8, or 10 hours post-gavage. Synovial fluid was analyzed to determine TVN and 3AT 
concentrations. TVN and 3AT were detected in Trial 1 at all time points, except 0 hour. At 2 
hours post-gavage for Trial 2, the mean concentrations peaked at 31.17 ng/mL (95% CI: 
18.62 – 52.16) for TVN and at 58.82 ng/mL (95% CI: 35.14 – 98.46) for 3AT.  Storage 
duration did not impact TVN or 3AT concentrations (p-value=0.9732).  
  
79 
 
 
Brief communication 
Tylvalosin (TVN) has been approved for oral administration through drinking water 
(50 ppm equivalent to approximately 5 mg/kg/day for five consecutive days) to control of 
porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in 
groups of swine in buildings experiencing an outbreak of PPE. Although extra-label use of 
tylvalosin to treat infectious arthritis caused by Mycoplasma spp. has been reported, detection 
and quantification of TVN in porcine synovial fluid has not been published to date. The 
objectives of this study were to determine if tylvalosin and its metabolite, 3-O-acetyltylosin 
(3AT) distribute to the synovial fluid of pigs at a target dose of 50 mg/kg (Trial 1) and at 
5mg/kg (Trial 2) after a single bolus via oral gavage. The label dose specifies administering 
the product at 50 ppm through the drinking water for five days. Based on estimated water 
consumption of 10% body weight, it is estimated that pigs would orally ingest 5 mg/kg of 
TVN throughout the course of one day. The objective of Trial 1 was to establish if TVN and 
3AT distribute to the synovial fluid.  As Trial 1 was a proof of concept trial, ten times label 
dose (50 mg/kg) was selected based on the hypothesis that a larger dose would result in 
larger TVN and 3AT concentrations in the joint which would increase the likelihood of 
detection of these compounds. As TVN and 3AT were detected in synovial fluid in Trial 1, 
Trial 2 then aimed to quantify joint concentrations under dosing conditions more similar to 
field administration. The dose chosen in Trial 2 reflected dosing rates used in the field (5 
mg/kg/day) while serving as a continuation of Trial 1 before proceeding to larger scale oral 
medication field trial. The stability of TVN and 3AT in synovial fluid samples stored at -
70°C for 7, 14, and 28 days was also evaluated in Trial 2.  
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In Trial 1, eight healthy pigs weighing approximately 22 kg were purchased from a 
high health commercial operation and housed in one indoor pen. In Trial 2, twenty-four 
clinically healthy pigs weighing approximately 45 kg each were housed in individual pens. A 
larger weight class was used in Trial 2 to facilitate the collection of sufficient quantities of 
joint fluid for the HPLC-MS analysis. Both studies were approved by the Iowa State 
University Institutional Animal Care and Use Committee. Pigs were fed an antibiotic-free, 
age-appropriate commercial diet of corn, soybean meal, dry distillers grains, and vitamin 
mineral premix ad libitum.  Feed was withheld from 12 hours prior to oral gavage until the 
end of the study.  
In Trial 1, one pig was randomly allocated to one of eight synovial fluid collection 
time points: 0, 1, 2, 3, 4, 6, 9, 12 hours post-gavage. In Trial 2, two pigs of each sex were 
randomly allocated to the following time points for synovial fluid collection: 0, 2, 4, 6, 8, 10 
hours post-gavage. Animals received tylvalosin at a target dose of 50 mg/kg and 5 mg/kg for 
Trial 1 and 2, respectively. Aivlosin Water Soluble Granules™ (62.5% w/w tylvalosin as 
tylvalosin tartrate, ECO Animal Health) was dissolved in water and administered in a single 
bolus by oral gavage.  Pigs were humanely euthanized at specified time points post-gavage 
and synovial fluid was collected aseptically via fine needle aspirate from all pigs. Synovial 
fluid samples with blood contamination were discarded. Synovial fluid samples collected 
from different leg joints were pooled by the individual pig and split into two aliquots (Trial 
1) or four aliquots (Trial 2) per pig. Aliquot one was tested immediately for the presence of 
TVN and 3AT.  Aliquot two, three (Trial 2 only), and four (Trial 2 only) were frozen 
at -70°C for 7, 14, and 28 days respectively and then analyzed for TVN and 3AT.  
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Concentrations of TVN and 3AT in porcine synovial fluid were measured with high-
pressure liquid chromatography (1260 Infinity Pump and Autosampler, Agilent) with mass 
spectrometry detection (ABSciex QTRAP 4500). Calibration standards were prepared by 
spiking 100 µL blank porcine synovial fluid to obtain final concentrations of 1, 2.5, 5, 10, 25, 
50, 100, 250, 500, and 1000 ng/mL. Quality control final concentrations were 3, 300, and 750 
ng/mL. Internal standard, roxithromycin, was added to each standard, unknown sample, and 
quality control sample at a concentration of 5 ng/mL. The samples were diluted with 900 µL 
of 0.1 molar ammonium acetate (pH 4.7), vortexed, and then centrifuged at 2000 rpm for 20 
minutes. The drug was extracted using Phenomenex Strata-X Polymeric Reverse Phase (33 
µm, 60 mg, 3 mL) solid phase extraction (SPE) cartridges. The SPE cartridge was 
conditioned with 2 mL of methanol, equilibrated with 2 mL of water, loaded with the sample, 
washed with 1 mL of 25% methanol in water and dried for 10 minutes. After elution with 2 
volumes of 0.75 mL acetonitrile, the sample was dried under a stream of nitrogen, 
reconstituted in 25% (v/v) acetonitrile in water, and transferred to an injection vial. The vials 
were spun down at 2000 rpm for 10 minutes. Injection volume was set to 10 µL.  The mobile 
phase consisted of A: 5 mM ammonium formate in water and B: 5mM ammonium formate in 
methanol at a flow rate of 0.3 mL/min. The mobile phase began at 35% B with a linear 
gradient to 85% B at 4 minutes which was maintained for 2 minutes, followed by a linear 
gradient to 98% B at 6.3 minutes, followed by re-equilibration to 35% B. Separation was 
achieved using a Phenomenex Gemini C18 column (50 x 2.0 mm, 3 µm particles, 110 Å) at 
room temperature.  The SRM transition used for quantitation of TVN was 108.8 and the 
transition for quantitation of 3AT was 814.5. 
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The standard curves of TVN and 3AT concentration determined using porcine 
synovial fluid were linear from 1 to 1000 ng/mL and were accepted when the correlation 
coefficient exceeded 0.99 and measured values were within 20% of the actual values. The 
lower limit of quantification (LOQ), was 1.0 ng/mL for all samples in Trial 1 and for samples 
in the 0, 7, and 14-day storage duration groups in Trial 2. The LOQ for the 28-day storage 
duration samples in Trial 2 was 2.5 ng/mL.  
No statistical analysis was performed on TVN and 3AT concentrations in Trial 1 due 
to the limited sample size per time point. For Trial 2, a linear mixed model (SAS 9.4) was 
generated to determine least squares means and 95% confidence intervals of the log 
concentration of TVN and 3AT at each sampling time and storage duration.  Concentration 
of TVN was log transformed to reduce skewed distribution of raw data and satisfy 
assumptions of normal distribution.  Drug (TVN or 3AT), storage duration time (0, 7, 14, and 
28 days) and sampling time (0, 2, 4, 6, 8, and 10 hours post-gavage) were fixed variables.  
The dose received by each pig was added into the model as a co-variable. Pig (one to 24) was 
entered as a random variable. Interactions between drug and storage time, drug and group, 
storage time and group, and drug/storage time/group were included in the model.   Partial F 
tests for fixed effects were conducted on the variables and interaction terms.   
Results from Trial 1 are shown in Table 1 and demonstrate that TVN and 3AT were 
detected in the synovial fluid of the study pigs. Figures 1 and 2 demonstrate the mean 
concentration and its 95% confidence intervals for TVN and 3AT respectively at 2, 4, 6, 8 
and 10 hours post gavage for all four storage durations evaluated. For the 0-hour time group, 
the synovial concentrations of both compounds were below the LOQ and are not included in 
the figures. 
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Sampling time point and drug (TVN or 3AT) significantly affected log concentration 
(both p-values <0.0001).  Dose was weakly significant and thus remained in the model (p-
value 0.0413). Storage duration did not impact the concentration of TVN and 3AT in the 
synovial fluid samples (p-value=0.9732).  
There is limited minimum inhibitory concentration (MIC) data available for 
Mycoplasma spp. associated with infectious arthritis in swine and a lack of randomized 
controlled trials evaluating tylvalosin in an experimentally induced or naturally occurring 
Mycoplasma spp. arthritis models. Ninety percent of tylvalosin MICs for M. hyosynoviae 
were reported to be <60 ng/mL (Rosener et al., 2013).  MIC data for Mycoplasma spp for 
3AT are not published to date and the antimicrobial activity of 3AT is unknown.  Clinical 
breakpoints have not been established for tylvalosin for any clinical scenario or pathogen. 
Tissue concentrations alone can be poor indicators of therapeutic efficacy for macrolides due 
to their propensity for intracellular accumulation. As a result, comparisons of synovial fluid 
concentrations to MIC values may be unrewarding in terms of predicting response to 
treatment.  Additional studies to correlate TVN and 3AT MIC information to clinical 
improvements are crucial for the judicious use of TVN for the treatment of infectious 
arthritis. In the field, tylvalosin is administered in solution through the water lines and daily 
dose is determined by the daily water intake of each animal. This dosing mechanism is more 
variable than administration by oral gavage and may affect joint concentrations of TVN and 
3AT attained in each pig. 
Trial 1 was a proof of concept study designed to establish if TVN and 3AT can be 
detected in the synovial fluid of pigs orally gavaged at ten times label dose. Based on the 
identification of TVN and 3AT in joint fluid in Trial 1, Trial 2 furthered this work by 
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quantifying synovial fluid concentrations of these compounds with a dosing rate more similar 
to the label dose.  Results from Trial 2 also demonstrated that TVN and 3AT concentrations 
remain stable for 28 days at -70°C in the joint fluid matrix. The authors are not aware of 
comparable studies or reports of the distribution and detection of TVN and 3AT in the 
synovial fluid of pigs for comparison. 
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(ng/mL) 
0 0.0 0.0 
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2 371.8 921.7 
3 334.9 1350.0 
4 246.7 422.7 
6 84.9 376.3 
9 95.9 377.6 
12 27.7 81.8 
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Abstract 
Tylvalosin (TVN) is a water-soluble macrolide antimicrobial used in swine 
production. The objective of this study was to determine the concentration of tylvalosin and 
its metabolite, 3-O-acetyltylosin (3AT), in the synovial fluid and plasma of growing pigs 
during five days of continuous water medication. 
Sixty healthy finisher pigs were housed individually with individual waterers. Three 
pigs of each sex were randomly allocated to the following time points for sample collection:  
0, 48, 60, 72, 84, 96, 102, 108, 114, and 120 hours on medication. TVN was administered 
daily in the water at a target concentration of 50 ppm. Water disappearance and medicated 
water concentration were measured daily. At each time point, six pigs were humanely 
euthanized and plasma and synovial fluid were collected for analysis.    
Mean TVN synovial fluid concentrations ranged between <1 ng/ml (hour 0) to 4.5 
ng/mL (hour 102). Synovial fluid and plasma concentration were moderately correlated 
(Pearson correlation coefficient of 0.9291). There was substantial variation between 
individual pigs in their daily water disappearance. Mean TVN water concentration ranged 
between 51 to 70 ppm. 
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Understanding variation between individual pigs in water intake, and subsequently 
ingested daily dose, is critical to ensuring animals are receiving an appropriate antimicrobial 
dose. 
Introduction 
Aivlosin® (65.5% w/w tylvalosin [TVN] tartrate, ECO Animal Health, London, UK) 
Water Soluble Granules (WSG) is a macrolide antibiotic with a zero-day meat withdrawal 
when administered in the drinking water (50 ppm tylvalosin) to pigs for five consecutive 
days in the United States. Anecdotally, tylvalosin has been reported to be effective in field 
conditions for treating Mycoplasma spp.-associated lameness. One previous study 
demonstrated that TVN and its metabolite (3-O-acetyltylosin, 3AT) can be found in the joints 
of healthy grower pigs after a single oral gavage at label dose (Canning et al., 2016). There is 
a need to expand on this study as gavage studies are not representative of field administration 
where pigs ingest portions of their daily dose at irregular intervals determined by their 
drinking behavior. The primary objective of this study was to determine the concentration of 
TVN and 3AT in the joints and plasma of healthy grower pigs during oral administration of 
Aivlosin® WSG through the drinking water for five consecutive days at label dose (50 ppm).  
The secondary objective was to quantify the correlation  between joint and plasma in terms 
of TVN concentration.  
Materials and methods 
Pigs and husbandry 
This study was approved by the Iowa State University Institutional Animal Care and 
Use Committee. Sixty healthy cross-bred pigs weighing approximately 45 kg were housed in 
individual pens. Pigs were acclimated to the individual pens for three days before the onset of 
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the study. Each pen was equipped with an individual pig waterer made from PVC pipe, 
which was the sole water source for each pig (Figure 1). The waterers were checked twice 
daily for proper function and troubleshooting leaking or plugged nipples, as needed.  Each 
waterer was designed to hold 2.5 times the anticipated daily water intake of a 60 kg pig.  At 
the same time daily, water disappearance was recorded for each pig and waterers were 
emptied and refilled with fresh, clean water. Water disappearance was recorded for each pig 
for two days (day -1 and 0) prior to the five-day medicated water administration (day 1 to 5).  
Pigs were fed an antibiotic-free, age-appropriate, commercial diet of corn, soybean 
meal, dry distillers grains, and vitamin mineral premix ad libitum. Pigs enrolled in the trial 
did not consume antibiotics in the water or feed nor were they given injectable antibiotics for 
at least 21 days prior to the commencement of the trial.  
Administration of drug 
On day one (hour 0) to day 5 (hour 120) animals received a target concentration of 50 
ppm TVN.  To accomplish this, TVN (Aivlosin® WSG, ECO Animal Health, London, UK) 
was dissolved in water as per label directions into clean bulk tanks and then dispersed 
manually to pigs in each of their individual waterers. A new medication solution was 
provided to each pig every 24 hours. A digital scale (Ozeri, San Diego, CA, USA) was 
calibrated daily and used to weigh the TVN granules for dissolution into the bulk mixing 
tanks. Water samples from each bulk mixing tank were collected daily for the duration of the 
five-day water medication and submitted for 3AT and TVN analysis.   
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Experimental Design 
Euthanasia and sample collection 
Three pigs of each sex were randomly allocated (www.random.org) to the following 
time points for sample collection:  0 (day one), 48, 60, 72, 84, 96, 102, 108, 114, and 120 
(day five) hours on medication. Hour 0 corresponds to 0700 (military time). There were ten 
sample collection time points in total over the five-day (120 hour) medication time period 
with six pigs per sample time point. At each time point, the six pigs were humanly 
euthanized using a penetrating captive bolt followed by exsanguination. A free catch, whole 
blood sample was collected in a heparin tube at exsanguination. At least one milliliter of 
synovial fluid was aseptically collected via fine needle aspirate from each pig. Synovial fluid 
samples with blood contamination were discarded. To attain sufficient volume, synovial fluid 
samples were collected from the tarsocrural and carpal joints were pooled by the individual 
pig. Whole blood samples were centrifuged for 5 minutes to reach 1000 g. The plasma was 
collected into a two milliliter cryotube (BD, Franklin Lakes, NJ, USA) and stored with the 
synovial fluid at -70°C prior to sample analysis.   
A systematic gross assessment of the internal organs of the pigs was completed at 
necropsy.  Any abnormalities were recorded and affected organs were submitted for further 
diagnostic investigation to the Iowa State University Veterinary Diagnostic Laboratory.  
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Analytical Procedures 
Water samples 
Concentration of TVN and 3AT in water samples were measured with high-pressure 
liquid chromatography (1260 Infinity Pump and Autosampler, Agilent, Santa Clara, CA, 
USA) with mass spectrometry detection ABSciex QTRAP 4500 (SCIEX, Framingham, MA, 
USA).  
Calibration standards were prepared by spiking 100 µL 25% acetonitrile in 10% 
formic acid to obtain final concentrations of 1, 2.5, 5, 10, 25, 50, 100, 250, 500, and 1000 
ng/mL. Quality control samples were 15, 300, and 750 ng/mL. Water samples were diluted 
by a factor of 200 with 25% acetonitrile in 10% formic acid. Internal standard, 
roxithromycin, was added to each standard, sample, and quality control at a final 
concentration of 250 ng/mL, vortexed, and centrifuged at 2000 rpm for 10 minutes. This 
protocol is as per the standard operating procedures of the Pharmacology Analytical 
Laboratory at the Iowa State University Veterinary Diagnostic Laboratory. 
Injection volume was 10 µL. The mobile phase consisted of A: 5 mM ammonium 
formate in water and B: 5 mM ammonium formate in methanol at a flow rate of 0.3 mL/min. 
The mobile phase began at 35% B with a linear gradient to 98% B at 6.3 minutes, followed 
by re-equilibration to 35% B. Separation was achieved using a Gemini C18 column (50 x 2.0 
mm, 3 µm particles, 110 Å, Phenomenex, Torrance, CA, USA) at room temperature. 
The standard curve of TVN and 3AT concentration was linear from 1 to 1000 ng/mL and was 
accepted when the correlation coefficient exceeded 0.95 and measured values were within 
20% of the actual values. 
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Synovial fluid and plasma samples 
The extraction and detection methods used to quantify TVN and 3AT in the synovial 
samples is reported in Canning et al. (2016). 
For plasma samples, the procedures reported in Canning et al. (2016) were performed 
using blank plasma in lieu of synovial fluid for the calibration curves. The plasma samples 
were diluted with 400 µL of acetonitrile containing 0.1% formic acid, vortexed, and 
centrifuged for 20 minutes at 630 g. The supernatant was poured off, dried down, and 
reconstituted with 200 uL of 25% (v/v) acetonitrile. The extraction and detection that 
followed was done as described in Canning et al. (2016).   
The standard curves for TVN and 3AT concentrations for both blank porcine synovial 
fluid and plasma were linear from 1 to 1000 ng/mL and were accepted when the correlation 
coefficient exceeded 0.95 and measured values were within 15% of the actual values. 
Statistical Analysis 
Descriptive statistics using SAS (9.4 SAS Institute Inc, Cary, NC) were performed to 
determine the mean and standard deviation for the concentration of TVN and 3AT in the 
plasma, synovial fluid, and water samples. A linear regression between the mean plasma 
TVN concentration and mean synovial TVN concentration for each group was performed. A 
Pearson correlation coefficient with 95% confidence intervals was conducted to assess 
correlation between the two sample types. For each pig, daily water disappearance, 
individual weight, and medicated water concentration were used to calculate a daily dose of 
TVN in milligrams per kilogram.  As some pigs were euthanized and sampled at twelve or 
six hour intervals, the calculated daily dose for these animals includes a partial daily dose.  
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Results 
Concentration of TVN and 3AT in synovial fluid and plasma 
Concentrations of TVN and 3AT for each sample time point for synovial fluid are 
summarized in Figure 2. For TVN, there are three time points (72, 96 and 108 hours), where 
there is at least one sample in which TVN was not detected in the joint fluid. For 3AT, the 
concentrations were less than TVN and at least one pig from every time point had a 3AT 
concentration of <1 ng/mL. 
The concentrations of TVN and 3AT in the plasma are summarized in Figure 3. There 
appears to be a diurnal pattern for TVN with the largest concentrations detected at evening 
time periods (60, 84, and 102 hours) and the smallest concentrations at morning time points 
(48, 72, and 96 hours). Mean plasma 3AT concentrations were similar to that of synovial 
concentrations and fluctuated between 0 and 2 ng/mL (Figure 3).  
Mean TVN concentrations were positively, linearly correlated between synovial and 
plasma samples (Figure 4). For the Pearson correlation coefficient, it was 0.9291 with a 95% 
confidence interval of 0.7217 to 0.9834 (p-value 0.0001). 
Medicated water concentration, daily water disappearance and daily dose 
The mean, standard deviation, and range of the medicated water concentration of the 
bulk bins are provided in Table 1.  
For day -1, the mean (standard deviation) water disappearance for all pigs was 4.7 L 
(0.22). For day 0, the mean (standard deviation) water disappearance for all pigs was 4.4 L 
(0.22). 
The mean and range of individual pig water disappearance and individual pig dose is 
provided in Table 2 for days 1 to 5 of medicated water administration.  
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On necropsy, there was lung consolidation affecting approximately 5% to 20% of the 
lung field identified in 22% (13/60) of the pigs. Diagnostic testing revealed chronic, non-
active pneumonia indicative of a previous bacterial or viral pathogen. No viral pathogens 
were identified with molecular testing. None of the waterers were identified as having faulty 
equipment during the trial.  
Discussion 
This study documents the concentrations of TVN and 3AT in the joints and plasma of 
healthy growing pigs over ten time points during a five-day water administration of TVN.  
The targeted daily dose for pigs for TVN is approximately 5 mg/kg. As evidenced in Table 2, 
this concentration was met or exceeded for most groups and the dose range within groups 
was relatively large. This appears to be influenced by variation in individual pig water 
disappearance. In groups with a large range in water disappearance, the range in daily dose 
was also large. Additionally, there were pigs at several time points with TVN concentration 
of <1 ng/mL (Figures 2 and 3). It is challenging to make comparisons between groups, as 
each treatment group contained different individual pigs with different drinking behaviors.  
Additionally, an important consideration is the limitation of the water delivery system which 
only allows assessment of water disappearance and not water intake. It is generally 
recognized that pigs will play with water nipples and that there will be water wastage when 
pigs drink from a water nipple.  Thus, the data reported here for daily drug dose are likely 
over estimates as they are calculated on the assumption that the pigs did not waste any water 
when drinking. The lack of observed leaky waterers may have reduced potential for 
difference between water intake and disappearance.  
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A key discussion point is that individual pig variation in water intake is a critical 
driver of daily ingested dose. More specifically, there is substantial variation between pigs on 
their water disappearance and therefore inter-pig variation in received drug dose. Some pigs 
may need injectable antimicrobial treatment to achieve and sustain therapeutic concentrations 
of antimicrobials, despite concurrent medication through the water. Unless pigs are 
demonstrating clinical signs while being observed by caretakers, it can be difficult to select 
pigs for individual treatment. Additionally, in groups of unhealthy pigs, individual variation 
in water intake is expected to increase (Pijpers et al., 1991). 
There are several studies in pigs reporting on daily dose for water soluble antibiotics, 
but none of the studies included TVN and few of them provide individual animal water 
intakes or disappearances (Agerso, Friis, & Haugegaard, 1998; L. Gutiérrez, 2011; Mason, 
Baynes, Almond, Riviere, & Scheidt, 2009; Pijpers et al., 1991; Soraci, Amanto, Tapia, de la 
Torre, & Toutain, 2014). One study examined plasma concentrations of tetracycline at four 
different concentrations in healthy pigs in individual pens with individual water carboys.  
Water consumption data was not reported other than to detail that water consumption was not 
different between treatment groups. There was, however, substantial variation between 
individual pig plasma concentration within each treatment group, which is consistent with the 
results of this study (Mason et al., 2009). 
As discussed in Canning et al. (2016), minimum inhibitory concentration (MIC) 
information for Mycoplasma spp. associated lameness in swine is limited. Clinical 
breakpoints and efficacy data from lameness challenge models or field studies for TVN have 
not been reported. Intracellular accumulation of macrolides poses an additional complexity to 
the interpretation and clinical application of MIC information (Giguère, 2013). MIC data for 
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3AT for Mycoplasma spp. are not available in peer reviewed literature to date but 3AT is 
believed to have antimicrobial activity (Giguère, 2013).   
There was variation in the TVN concentration in the stock solution bins (Table 1) 
despite efforts to minimize this. Specifically, consistent procedures and the same people were 
used to mix the solution each day and weights and mixing calculations were verified by two 
people. Collecting multiple samples per bin may have helped better understand and quantify 
the variation in bin concentrations.  
Plasma and synovial fluid concentrations were positively, linearly, and moderately 
correlated. Plasma could be an acceptable sample to collect in lieu of synovial fluid in future 
pharmacokinetic studies on TVN. Utilization of plasma would decrease the number of pigs 
required for studies because it would allow for repeated sampling of individual pigs.   
This study reports on the concentration of TVN and 3AT in the synovial fluid and plasma of 
pigs medicated with TVN in the water for five days.  Understanding and quantifying the dose 
variation amongst individual pigs in a mass medication scenario is important to ensuring that 
individual animals are receiving the intended and appropriate dose of antimicrobial.  
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Figure 1.  Depiction of the individual pig housing. The PVC pipe waterer the pig is drinking 
from was the only source of water for the pig.  The bowl waterer in the picture was not 
functional.  
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Figure 2: Mean concentration of tylvalosin (TVN) and 3-O-acetyltylosin (3AT) in the 
synovial fluid of pigs across ten time periods during the study period. The bars above and 
below each marker represent the minimum and maximum concentration in each group. 
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Figure 3. Mean concentration of tylvalosin (TVN) and 3-O-acetyltylosin (3AT) in the plasma 
of pigs across ten time periods during the study period. The bars above and below each 
marker represent the minimum and maximum concentration in each group. 
102 
 
 
 
Figure 4. Linear correlation between mean concentration of tylvalosin (TVN) in the plasma 
and mean concentration of TVN in the synovial fluid for each of the ten sample groups. R 
squared was 0.86. The slope on the linear regression equation was 1.290 and the intercept 
was 0.836. 
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Table 1.  Mean concentration, standard deviation and range of tylvalosin (TVN) and 
3-acetyltylosin (3AT) in the bulk tank medicated water samples. 
Day of 
medicated 
water 
administration 
Number 
of bulk 
tank 
samples* 
Mean 
concentration 
(ppm) 
Standard 
deviation 
Range: 
Low (ppm) 
Range: 
High (ppm) 
TVN 3AT TVN 3AT TVN 3AT TVN 3AT 
Day 1 6 62 2 5.3 0.4 54 1 67 2 
Day 2 6 51 1 8.8 0.0 38 1 59 1 
Day 3 5 61 1 8.7 0.4 51 1 75 2 
Day 4 4 59 1 4.2 0.0 55 1 62 1 
Day 5 2 70 2 2.1 0.0 68 2 71 2 
*The volume of each bulk tank was constant each day. A medicated water sample was 
taken from each bulk tank mixed and distributed to pigs each day. The number of bulk 
tanks required each day decreased as groups of pigs were euthanized.  
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Table 2. Concentration of tylvalosin (TVN) in the medicated water, individual pig 
water disappearance and individual pig dose of TVN for the five days of water 
medication (day one to day five). 
Day of 
trial 
Sample 
Group 
(6 pigs 
per 
group) 
Hours of 
water 
access per 
dayǂ 
TVN 
concentration 
in water (ppm) 
Individual pig 
water 
disappearance 
(L) 
Individual pig 
dose of TVN 
(mg/kg) 
   
Mean Mean Range Mean Range 
1 2 to 10 24 hours 61.1 3.5 6.3 5.3 8.2 
2 2 to 10† 24 hours 50.9 4.6 6.4 5.2 6.7 
3* 3 12 hours 51.0 3.6 1.2 4.4 2.6 
3 4 24 hours 51.0 3.8 3.4 4.9 4.9 
3 5 24 hours 75.0 4.1 2.9 6.7 2.6 
3 6 24 hours 61.0 4.8 2.2 6.7 2.9 
3 7 24 hours 61.0 4.4 2.2 5.8 2.7 
3 8 24 hours 61.0 4.5 5.3 5.7 6.3 
3 9 24 hours 61.0 4.8 3.1 6.4 5.8 
3 10 24 hours 58.0 5.3 2.8 6.9 3.6 
4** 5 12 hours 62.0 3.3 3.7 4.3 3.7 
4 6 24 hours 64.0 4.8 3.3 6.8 3.1 
4 7 24 hours 64.0 4.7 2.4 6.4 2.2 
4 8 24 hours 55.0 4.8 2.8 5.6 2.7 
4 9 24 hours 55.3 4.3 2.4 5.2 3.5 
4 10 24 hours 57.0 4.4 3.5 5.6 3.9 
5*** 7 6 hours 68.0 2.2 1.4 3.2 1.8 
5 8 12 hours 68.0 3.3 3.4 4.6 4.2 
5 9 18 hours 71.0 4.0 2.4 6.1 5.1 
5 10 24 hours 71.0 4.3 2.7 6.8 4.2 
ǂPigs were sampled at 12 and 6 hour intervals during the study. As a result, water 
disappearance and dose (mg/kg) information reflects the number of hours the pig had access to 
the medicated water in each of the five 24 hour periods during the 5-day water medication. For 
each day, the number of hours each group of six pigs had access to medicated water is 
reflected in this column. 
*Pigs from groups 1 and 2 were removed prior to day 3 as per the sampling schedule 
**Pigs from groups 3 to 4 were removed prior to day 4 as per the sampling schedule 
***Pigs from groups 5 to 6 were removed prior to day 5 as per the sampling schedule 
†One pig in group 8 did not have water disappearance recorded for day 2 due to a data 
recording error and is not included in any subsequent results reported in this row 
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CHAPTER 7. CONCLUSIONS 
From the retrospective review of lameness cases involving joints and legs at the ISU 
VDL, it was demonstrated that there are four primary diagnosis that made up approximately 
80% of the 464 cases assessed. These four diagnoses included Mycoplasma hyosynoviae, 
infectious arthritis (bacterial), metabolic bone disease, and lameness with inconclusive 
findings. This is consistent with practitioner reports that it is not uncommon for diagnostic 
investigations on lameness to generate non-specific findings as this category represented the 
largest number of cases in the review.  Additionally, a secondary diagnosis was identified in 
about 25% of cases. This indicates that lameness etiologies are likely multifactorial. This 
review also highlighted the challenges of accounting for the numerous biases involved with 
sample collection, diagnostic submissions and retrospective review process itself.  Based on 
these findings, it is likely that a singular diagnostic investigation is insufficiently 
comprehensive to adequately identify contributing etiologies in complex multifactorial cases. 
Despite this, the diagnostic investigation process is an important and essential tool for 
practitioners for the clinical management of infectious lameness.  Additional diagnostic tools 
and systematic approaches to clinical assessment and sample collection would complement 
and augment most diagnostic submissions for lameness.  
In Chapters 3 and 4, the development and refinement of fluid analysis and cytologic 
evaluation of swine joint fluid was explored from two perspectives. First, in Chapter 3, the 
question of feasibility of attaining antemortem joint fluid samples was assessed using several 
anesthetic protocols. Telazol, ketamine and xylazine were found to be the most effective 
combination for successful antemortem sample collection with the least recovery time and 
cost. It is essential that veterinarians review FDA guidances and statements about the use of 
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anesthetic agents in food animals and make an informed decision before using anesthetic 
agents for lameness work-ups. Secondly, in Chapter 4, joint fluid samples were analyzed to 
produce reference intervals for the carpus and tarsus for fluid analysis and cytology variables. 
Previously, these reference intervals were not available with the public body of literature.  
Practitioners can submit freshly collected joint fluid samples for clinical pathology and 
compare samples from lame pigs to the reference intervals published here. In addition to 
PCR and culture, clinical pathology results provide additional information about the 
pathological process occuring in the joints and are a critical tool especially for antemortem 
sampling when synovium is not accessible. As has been published for other species, it will be 
important to further define and characterize specific changes to clinical pathology variables 
with respect to different swine-specific pathogens and pathological processes to solidify 
clinical pathology as a useful tool for swine practitioners. 
 The last section of the dissertation addressed the lack of swine pharmacology data 
specific to joints. The focus of Chapters 5 and 6 were to determine if tylvalosin 
concentrations could be detected in synovial fluid and if so, to determine joint concentrations 
over the course of a five-day oral administration of the product. Tylvalosin and its metabolite 
were identified in joint fluid after oral gavage at label and ten times the label dose. This 
information gave rise to Chapter 6 where tylvalosin concentrations in synovial fluid were 
assessed under field-like conditions of administration. This project demonstrated that there 
was substantial individual pig variation in water disappearance and, consequently, joint 
concentration levels, between healthy, individually housed pigs.  From a clinical 
management perspective, this information reinforces that it is imperative to ensure pigs are 
drinking medicated water during a treatment course. Lame and depressed pigs may need 
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injections in additional to site-wide water medication as their water intake will be decreased. 
Additionally, tylvalosin concentrations were below 1 ng/mL for some pigs indicating that 
steady state concentrations were not reached in individual pigs during the medication course. 
This is likely related to the half-life of the drug and individual pig drinking behavior. Lastly, 
this chapter provides data to support the use of plasma in lieu of synovial fluid for measuring 
tylvalosin concentrations as the concentrations in both of these samples are highly correlated. 
The use of plasma would allow for repeated, antemortem, sampling of individual pigs and 
would greatly facilitate sample collection for future projects.  
 As introduced in the literature review and statement of aims, the diagnosis and 
treatment of infectious arthritis in growing pigs is a broad topic. To address knowledge gaps 
in our understanding of infectious arthritis, the approach of this dissertation has been on 
applied projects to support the clinical management of IA in the field. Within that scope, 
there are many directions and opportunities for future projects based on this work. Amongst 
those, the top priority for future research would be the execution of challenge models and/or 
field trials to evaluate the efficacy of antimicrobials for infectious arthritis and to further 
elucidate clinical pathology changes associated with specific pathogens. 
 
 
 
 
 
 
 
